<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<!--
-->
<!-- %html{'xmlns'=>'http://www.w3.org/1999/xhtml', 'xml:lang'=>'en', 'lang'=>'en'} -->
<html>
<head>
<script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"beacon-1.newrelic.com","errorBeacon":"jserror.newrelic.com","licenseKey":"d64d3db899","applicationID":"125361","transactionName":"dAkNQBFbXFUEREkBCVQTDlENQB9dDlUTCANZEkxHC1tH","queueTime":0,"applicationTime":2178,"ttGuid":"","agentToken":null,"agent":"js-agent.newrelic.com/nr-298.min.js","extra":""}</script>
<script type="text/javascript">window.NREUM||(NREUM={}),__nr_require=function a(b,c,d){function e(f){if(!c[f]){var g=c[f]={exports:{}};b[f][0].call(g.exports,function(a){var c=b[f][1][a];return e(c?c:a)},g,g.exports,a,b,c,d)}return c[f].exports}for(var f=0;f<d.length;f++)e(d[f]);return e}({"4O2Y62":[function(a,b){function c(a,b){var c=d[a];return c?c.apply(this,b):(e[a]||(e[a]=[]),void e[a].push(b))}var d={},e={};b.exports=c,c.queues=e,c.handlers=d},{}],handle:[function(a,b){b.exports=a("4O2Y62")},{}],YLUGVp:[function(a,b){function c(){var a=m.info=NREUM.info,b=m.proto="https"===l.split(":")[0]||a.sslForHttp?"https://":"http://";if(a&&a.agent&&a.licenseKey&&a.applicationID){f("mark",["onload",e()]);var c=h.createElement("script");c.src=b+a.agent,h.body.appendChild(c)}}function d(){"complete"===h.readyState&&f("mark",["domContent",e()])}function e(){return(new Date).getTime()}var f=a("handle"),g=window,h=g.document,i="readystatechange",j="addEventListener",k="attachEvent",l=(""+location).split("?")[0],m=b.exports={offset:e(),origin:l};h[j]?(h[j](i,d,!1),g[j]("load",c,!1)):(h[k]("on"+i,d),g[k]("onload",c)),f("mark",["firstbyte",e()])},{handle:"4O2Y62"}],loader:[function(a,b){b.exports=a("YLUGVp")},{}]},{},["YLUGVp"]);</script>
<title>
United States ex rel. Jones v. Brigham & Women's Hosp., 678 F.3d 72 (1st Cir. 2012), Court Opinion - Bloomberg Law 

</title>
<meta content='NOINDEX, NOFOLLOW' name='ROBOTS'>
<meta content='telephone=no' name='format-detection'>
<meta content='BLAW' name='apple-mobile-web-app-title'>
<meta name="csrf-param" content="authenticity_token"/>
<meta name="csrf-token" content="NiJ+70&#47;qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA="/>
<script src="/min_assets/framework.js?1389213936" type="text/javascript"></script>

<script src="/javascripts/daterange.js?1380743058" type="text/javascript"></script>
<script src="/javascripts/document/document.js?1382459272" type="text/javascript"></script>
<script src="/javascripts/document/document_viewer.js?1383685414" type="text/javascript"></script>
<script src="/javascripts/document/bciteutils.js?1388683076" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.query.js?1342203941" type="text/javascript"></script>
<script src="/javascripts/browser/browser.js?1387565892" type="text/javascript"></script>
<script src="/javascripts/document/image_viewer.js?1366129555" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.selection.js?1375450295" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.bb-copywithcitation.js?1383771008" type="text/javascript"></script>
<script src="/javascripts/document/copy_with_cite.js?1382560939" type="text/javascript"></script>
<script src="/javascripts/document/notepad.js?1366310522" type="text/javascript"></script>

<link href="/stylesheets/yui2/yui2_combo.css?1288273584" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document_v2.css?1391022004" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/min_assets/framework.css?1391022047" media="screen,print" rel="stylesheet" type="text/css" />
<!--[if IE]>
<link href="/stylesheets/ie.css?1391022010" media="screen,print" rel="stylesheet" type="text/css" />
<![endif]-->
<link href="/stylesheets/search/search_results.css?1391022036" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document.css?1391022003" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document_viewer.css?1391022005" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/search/tree_view.css?1391022037" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/browser/browser_enhanced.css?1391021984" media="print,screen" rel="stylesheet" type="text/css" />
<style type='text/css'>
#content_document, #content_document h1, #content_document h2, #content_document h3, #content_document h4, #content_document h5, #content_document h6 { font-family:Times New Roman, Times, serif; }
				#content_document pre {
				white-space: pre-wrap;
				white-space: -moz-pre-wrap;
				white-space: -pre-wrap;
				white-space: -o-pre-wrap;
				word-wrap: break-word;
				font-family: Bloomberg Fixed 2 Unicode;
			}
			
			#content_document .page_no { 
				font-weight:bold;
				text-decoration:none;
			}
			
			#content_document .highlight { 
				font-weight:bold; 
				background-color:yellow; 
				color:black;
			}
			
			#content_document .bcitehi { 
				font-weight:bold; 
				background-color:violet; 
				color:black;
			}
			
			/*.UNICODE {
			}
			
			#content_document blockquote {
			}
			
			#content_document em {
			}   
			
			#content_document .tableofcontents {
			}
			
			#content_document div.blockgroup {
			}
			
			#content_document p.opinion_text {
			}  */
			
			#content_document, #content_document h1, #content_document h2, #content_document h3, #content_document h4, #content_document h5, #content_document h6, #content_document p, #content_document li, #content_document td, #content_document th, #content_document div {
				font-size: 11pt;
			}
			
			#content_document .main {
				text-align:center; 
				font-weight:bold; 
				color:black;
			}
			
			#content_document .ftnote { 
				font-style:italic;
			}
			
			#content_document .headline {
				font-weight:bold; 
				color:black;
			} 
			
			#content_document p.group{
				padding-top: 0; 
				padding-bottom: 1px; 
				padding-left: 0; 
				padding-right: 0;
				margin-top: 0; 
				margin-bottom: 1px; 
				margin-left: 0; 
				margin-right: 0;
			}
			
			#content_document .big {
				font-size: 13pt;
			}
			
			#content_document .indent {
				text-indent:2.5em;
			}
			
			#content_document .level2 {
				margin-left:2.5em;
				margin-right:2.5em;
			} 
			
			#content_document .level3 {
				margin-left:5em;
				margin-right:5em;
			} 					
			
			#content_document .level4 {
				margin-left:7.5em;
				margin-right:7.5em;
			} 					
			
			#content_document .level5 {
				margin-left:10em;
				margin-right:10em;
			} 					
			
			#content_document .level6 {
				margin-left:12.5em;
			} 					
			
			#content_document a.sup {
				font-size: 6pt; 
				vertical-align: top;
			}
			
			#content_document a.sup1 {
				font-size: 8pt; 
				vertical-align: top;
			}
			
			#content_document em.italic {
				font-style: italic;
			}
			
			#content_document em.bold {
				font-weight: bold;
				font-style: normal;
			}
			
			#content_document em.bold-big {
				font-size: 13pt; 
				font-weight: bold;
			}
			
			#content_document em.underline {
				font-style:normal; 
				text-decoration: underline;
			}
			
			#content_document em.bold-ital {
				font-weight: bold; 
				font-style: italic;
			}
			
			#content_document em.bold-underline {
				font-weight: bold; 
				text-decoration: underline;
			}
			
			#content_document em.ital-underline {
				font-style: italic; 
				text-decoration: underline;
			}
			
			#content_document em.ital-bold-underline { 
				font-style: italic; 
				font-weight: bold; 
				text-decoration: underline;
			}
			
			#content_document em.small-cap {
				font-style:normal; 
				font-variant: small-caps;
			}
			
			#content_document em.strike {
				font-style: normal;
				text-decoration: line-through;
			}
			
			#content_document .small-cap {
				font-style:normal; 
				font-variant: small-caps;
			}
			
			#content_document h1.organization {
				font-weight: bold; 
				text-align:center; 
				font-style: normal;
			} 
			
			#content_document h2.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:2.5em; 
				margin-right:2.5em;
			}
			
			#content_document h3.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:5em; 
				margin-right:5em;
			}
			
			#content_document h4.organization {
				font-weight: bold;
				text-align:left;
				margin-left:7.5em; 
				margin-right:5em;
			}
			
			#content_document h5.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:10em; 
				margin-right:5em;
			}
			
			#content_document h2.citation {
				font-weight: bold; 
				text-align:left;
			}
			
			#content_document div.blcitation {
				font-size: 7pt; 
				text-align:center;
			}
			
			#content_document .italic {
				font-style:italic;
			}	
			
			#content_document ul.dash {
				list-style-type: none;
			}
			
			#content_document ul.bullet {
				list-style-type: disc;
			}
			
			#content_document ul.none {
				list-style-type: none;
			}
			
			#content_document li.off {
				list-style-type: none; 
			}
			
			#content_document .mypre { 
				font-size: 100%;
			}
			
			#content_document .TOC {
				text-align:left;  
				padding:5px;  
				margin:0 auto;  
				color: #000000;  
				font-weight: 500;
			}
			
			#content_document .TOC hr { 
				color:#339999;  
				background-color:#339999;  
				width:100%;  
				clear: both;  
				border: none;
			}
			
			#content_document .bluehr { 
				color:#339999;  
				background-color:#339999;  
				width:100%;  
				clear: both;  
				border: none;
			}
			
			#content_document .headinga { 
				color: #339999;   
				font-size: 20px;
				font-weight: 500;
				text-align: center;
			}
			
			#content_document .tocentry {
				text-indent:-18px;
				padding-left:18px;
				color: #003399;
				font-weight: 700;
			}
			
			#content_document .doctext {  
				margin:0 auto;  
				text-align: left;  
			}				 
			
			#content_document span.PAGE { 
				color: black; 
				font-weight: bold 
			}
			
			#content_document a:link {  	
				color: #003399;  
				font-weight: 700;
			}
			
			#content_document a:visited {  
				color: #660066;   
				font-weight: 700;
			}
			
			#content_document .fn{  
				padding-left: 50 px; 
				font-weight: 550;
			}				
			
			#content_document .fr a:link {  
				color: #003399;  
				font-weight: 600;
			}
			
			#content_document .fr a:visited {  
				color: #660066;  
				font-weight: 600;
			}
			
			#content_document .headinga { 
				color: #339999;   
				font-size: 20px;
				font-weight: 600;
				text-align: center;
			}
			
			#content_document .volume {  
				text-align:center;  
				padding:5px;  
				margin:0 auto;  
				color: #000000;  
				font-weight: 500;
			}				
			
			#content_document h2.blcitation {
				font-size: 7pt; 
				text-align:center; 
				white-space:nowrap;
			}
			
			#content_document cite.blcitation {
				white-space:nowrap;
			}
			
			#content_document table.page_legend { 
					width: 100px; 
					text-align: left; 
					background-color: white; 
					font-family: Bloomberg Proportional Unicode;
					font-size: 12px
			}
			#content_document div.page_text {  padding-left: 50 px; margin:0 0 0 50px;  text-align: center;  width:100px; font-size: 12px}

			#content_document .smalllinks{  text-align: right;  font-size: 10px;  font-weight: 500;}		
			
			#content_document .opinion_headnotes{
				margin-top:6px;
				margin-bottom:6px;
			}
			
			#content_document .headnote_group{
				padding: 10px 10px 2px 10px;
				background-color: #ECECEC;
				margin-top:4px;
				margin-bottom:10px;
			}
			
			#content_document .headnote_group_header{
				font-weight: bold;
				margin-bottom: 8px;
			}
			
			#content_document .opinion_headnote{
				clear:both;
				padding-bottom: 4px;
				margin-bottom:10px;
			}
			
			#content_document .highlighted_headnote{
				background-color: #FFFF22;
			}
			
			#content_document .headnote_link{
				font-weight:bold;
				text-decoration: none;
			}
			
			#content_document .show_hide_headnotes{
			}
			
			#content_document .clearfix:after {
				clear:both;
				content: ".";
				height:0px;
				display:block;
				visibility:hidden;
			}
			
			/* BNA Headnotes */
			
			#content_document .headnotesContainer {
				margin: 12px 0;
				padding: 12px 0;
				border-top: 1px solid #000;
				border-bottom: 1px solid #000;
			}
			
			#content_document .headnotesContainer .headnotesContainerTitle {
				font-size: 16px;
				font-weight: bold;
				text-align: center;
			}
			
			#content_document .headnotesContainer .headnoteTitle {
				padding: 8px 12px;
				background-color: #dedede;
				margin: 24px 0 0 0;
				font-size: 16px;
				font-weight: bold;
				text-transform: uppercase;
			}
			
			#content_document .headnotesContainer .headnote {
				margin-left: 24px;
			}
			
			#content_document .headnotesContainer .headnote .headnoteSlug {
				margin-top: 12px;
				font-size: 16px;
				font-weight: bold;
			}
			
			#content_document .headnotesContainer .headnote .headnoteDescriptor {
				margin-top: 12px;
				font-weight: bold;
			}
			
			#content_document .headnotesContainer .headnote .headnoteToggle .headnoteText {
				margin-bottom: 12px;
			}
		
</style>
<link href="/stylesheets/yui_calendar.css?1391022047" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/docviewer_overrides.css?1391022005" media="print,screen" rel="stylesheet" type="text/css" />

<link href="/stylesheets/print.css?1391022029" media="print" rel="stylesheet" type="text/css" />
<link href='/images/favicon.ico' rel='shortcut icon'>
</head>
<body class='securities  document '>
<div class='container'>
<div id='page_loader'></div>
<div class='printHeader printOnly'>
<img src='/images/print_header.jpg'>
<div class='user'>
<span>
Prepared for: Susan Yeh
</span>
</div>
</div>
<div class='topBarHolder printHide'>
<div class='topBar'>
<ul class='topBarElements'>
<li class='skip'>
<a href="#primary_content" tabindex="1">Skip Navigation</a>
</li>
<li class='logout'>
<a href="/log_out.htm" id="logoutButton" onclick="generateExplicitLogoutEvent();">Logout</a>
</li>
<li id='help'>
<a href="/help" target="_blank">Help</a>

</li>
<li id='user'>
<a href="/settings">Susan Yeh</a>

</li>
<li class='withNotifications' id='client_matter'>
<div class='clientMatterDropDown'>
<div>Client Matter</div>
<div class='skinButton blueAlert' style='display:none'>
<span id='currentClientMatter'>

</span>
</div>
<span class='noneSelected' style=''>
&nbsp;(None Selected)
</span>
<div class='expandable'></div>
</div>
<div class='topNavDropdown' id='sub_client_matter'>
<ul>
<li style='display:none'>
<a class='remove_client_matter_menu_item' href='#' onclick='return true;' title='Remove Current Client Matter'>
Remove Current Client Matter
</a>
</li>
<li>
<a class='enter_client_matter_menu_item' href='#' onclick='return true;' title='Enter Client Matter'>
Enter Client Matter
</a>
</li>
</ul>
</div>

</li>
<li class='withNotifications' id='alerts'>
<a href="/alerts/inbox"><div id='unreadAlertsCount'>
Saved Searches & Alerts
</div>
</a>
</li>
<li class='withNotifications' id='downloads'>
<a href="/download/download_center"><div id='unreadDownloadsCount'>
<div>Downloads</div>
</div>
</a>
</li>
<li id='research_trail'>
<a href="/research_trail"><div>Research Trail</div>
</a>
</li>
<li id='workspaces'>
<a href="/workspaces"><div>Workspaces</div>

</a></li>
</ul>
</div>
</div>

<div class='topMenu textBkDark printHide' id='top_menu'>
<div class='contextHolder'>
<a href='/home'>
<h1 class='logo'></h1>
</a>
<div class='menuRow'>
<ul class='menuItems'>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_HOME' onclick="javascript:navigation_selectMenuItem('HOME');">
Home
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button active' id='nav_menu_button_search' onclick="javascript:navigation_selectMenuItem('search');">
Search & Browse
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_practice_areas' onclick="javascript:navigation_selectMenuItem('practice_areas');">
Practice Centers
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_LITIGATION' onclick="javascript:navigation_selectMenuItem('LITIGATION');">
Litigation & Dockets
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_transactional' onclick="javascript:navigation_selectMenuItem('transactional');">
Transactional Law
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_LEG_REG' onclick="javascript:navigation_selectMenuItem('LEG_REG');">
Legislative & Regulatory
</a>
</li>
<li class='legalAnalysis' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_news' onclick="javascript:navigation_selectMenuItem('news');">
Legal Analysis & News
</a>
</li>
<li class='last' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_market' onclick="javascript:navigation_selectMenuItem('market');">
Companies & Markets
</a>
</li>

</ul>
</div>
<form accept-charset="UTF-8" action="/autocomplete/jump" id="search_form" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<input id='quicksearch_context' name='context_value' type='hidden' value='PRACTICE'>
<div class='searchBox' id='quick_search'>
<div class='inputContainer'>
<input autocomplete='off' id='quick_search_term' name='term' onkeydown='framework_handleTextInput(event,quick_search_term)' tabindex='2' type='text'>
<div class='searchButton' onmouseup='return framework_activateForm();' tabindex='3'></div>
<a href="/help/BLAWHelpSystem.htm#GO_Using_the_GO_BAR.htm" class="infoBtn" target="_blank" title="Using the &lt;GO&gt; Bar"></a>
<input id='quick_search_post' name='qs_type' type='hidden' value='general'>
<input id='quick_search_type' name='type' type='hidden' value='input_terms'>
<input id='quick_search_value' name='item_value' type='hidden'>
<input id='quick_search_origin' name='search_type' type='hidden' value='LAW'>
</div>
</div>
</form>


</div>
</div>

<div class='main clearfix'>
<div class='menuDrawer'>
<div class='interior'>
<div class='drawer_shade drawerShade clearfix'>
<div class='dropShadow'></div>
<div class='sub_menu subMenu' id='sub_menu_HOME'>
<table>
<tr>
<td class=''>
<ul>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_search'>
<div class='subTitles'>
<div class='subItem one '>
Search
</div>
<div class='subItem two '>
Specialized Searches
</div>
<div class='subItem one last'>
Browse
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class=''>
<ul>
<li class='last'>
<a class='clearfix' href='/legal_search'>
<div class='navLinkTitle'>
All Legal Content
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/company_search'>
<div class='navLinkTitle'>
Company Screener
</div>
</a>
</li>
<li>
<a class='clearfix' href='/opinion_search'>
<div class='navLinkTitle'>
Court Opinions
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dealmaker_document_search'>
<div class='navLinkTitle'>
DealMaker Documents
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets'>
<div class='navLinkTitle'>
Dockets
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dnds_search'>
<div class='navLinkTitle'>
Domain Name Decisions
</div>
</a>
</li>
<li>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
EDGAR
</div>
</a>
</li>
<li>
<a class='clearfix' href='/clthreads/company-search-clc.php' target='_blank'>
<div class='navLinkTitle'>
EDGAR Comment Threads
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/leg_search'>
<div class='navLinkTitle'>
Legislative
</div>
</a>
</li>
<li>
<a class='clearfix' href='/news/advanced_search'>
<div class='navLinkTitle'>
News
</div>
</a>
</li>
<li>
<a class='clearfix' href='/patent_search'>
<div class='navLinkTitle'>
Patents
</div>
</a>
</li>
<li>
<a class='clearfix' href='/people_search'>
<div class='navLinkTitle'>
People
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_search'>
<div class='navLinkTitle'>
Regulatory
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/no_action_search'>
<div class='navLinkTitle'>
SEC No-Action Letters
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/law_reports'>
<div class='navLinkTitle'>
BNA Law Reports
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.456024'>
<div class='navLinkTitle'>
BNA Manuals
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.456026'>
<div class='navLinkTitle'>
BNA Portfolios
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.102923'>
<div class='navLinkTitle'>
Books & Treatises
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.293113'>
<div class='navLinkTitle'>
Federal Law
</div>
</a>
</li>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Law
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_practice_areas'>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/antitrust'>
<div class='navLinkTitle'>
Antitrust
</div>
</a>
</li>
<li>
<a class='clearfix' href='/banking_finance'>
<div class='navLinkTitle'>
Banking & Finance
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/bankruptcy'>
<div class='navLinkTitle'>
Bankruptcy
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/corporate_ma'>
<div class='navLinkTitle'>
Corporate/M&A
</div>
</a>
</li>
<li>
<a class='clearfix' href='/employee_benefits'>
<div class='navLinkTitle'>
Employee Benefits
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/health'>
<div class='navLinkTitle'>
Health
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/ip_law'>
<div class='navLinkTitle'>
Intellectual Property
</div>
</a>
</li>
<li>
<a class='clearfix' href='/labor_employment'>
<div class='navLinkTitle'>
Labor & Employment
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/securities'>
<div class='navLinkTitle'>
Securities
</div>
</a>
</li>
<li>
<a class='clearfix' href='/tax'>
<div class='navLinkTitle'>
Tax
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_LITIGATION'>
<div class='subTitles'>
<div class='subItem two '>
Litigation
</div>
<div class='subItem two last'>
Dockets
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/opinion_search'>
<div class='navLinkTitle'>
Search Court Opinions
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_menu/X7TO28O'>
<div class='navLinkTitle'>
BNA Outlines & Headnotes
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_content_menu/105.103000'>
<div class='navLinkTitle'>
Federal Rules
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/general'>
<div class='navLinkTitle'>
Litigation Resources
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/dockets'>
<div class='navLinkTitle'>
Search Dockets
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets/breaking'>
<div class='navLinkTitle'>
Breaking Complaints
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dockets/analytics'>
<div class='navLinkTitle'>
Docket Analytics
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/dockets/coverage'>
<div class='navLinkTitle'>
Docket Coverage
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets/requests'>
<div class='navLinkTitle'>
Docket Requests
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dockets/tracking'>
<div class='navLinkTitle'>
Docket Tracking
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_transactional'>
<div class='subTitles'>
<div class='subItem two '>
Search
</div>
<div class='subItem two last'>
Resources
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
EDGAR
</div>
</a>
</li>
<li>
<a class='clearfix' href='/clthreads/company-search-clc.php' target='_blank'>
<div class='navLinkTitle'>
EDGAR Comment Threads
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/example_and_saved_searches'>
<div class='navLinkTitle'>
Example Searches
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/dealmaker_document_search'>
<div class='navLinkTitle'>
DealMaker Documents
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dealmaker_clause_search'>
<div class='navLinkTitle'>
DealMaker Clauses
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/deal_maker/current_awareness'>
<div class='navLinkTitle'>
Current Awareness
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_menu/X7TS80O'>
<div class='navLinkTitle'>
Drafting Guides & Overviews
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_menu/X7TVS0O'>
<div class='navLinkTitle'>
Transactional Legal Treatises
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/deal_maker/resources'>
<div class='navLinkTitle'>
Transactional Resources
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_LEG_REG'>
<div class='subTitles'>
<div class='subItem two '>
Legislative
</div>
<div class='subItem two last'>
Regulatory
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/leg_search'>
<div class='navLinkTitle'>
Search Legislative
</div>
</a>
</li>
<li>
<a class='clearfix' href='/leg_search/congressional_bill_search'>
<div class='navLinkTitle'>
Search Congressional Bills
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_browser/105.24221'>
<div class='navLinkTitle'>
U.S. Code
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Legislative Materials
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/leg_news_analysis'>
<div class='navLinkTitle'>
Legislative Resources
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/reg_search'>
<div class='navLinkTitle'>
Search Regulatory
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_search/federal_register_search'>
<div class='navLinkTitle'>
Search Federal Register
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_browser/105.24230'>
<div class='navLinkTitle'>
Code of Federal Regulations
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Regulatory Materials
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_updates'>
<div class='navLinkTitle'>
Monitor Regulators
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/reg_news_analysis'>
<div class='navLinkTitle'>
Regulatory Resources
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_news'>
<div class='subTitles'>
<div class='subItem two '>
Legal Analysis
</div>
<div class='subItem two last'>
News
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/law_reports'>
<div class='navLinkTitle'>
BNA Law Reports
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_content_menu/105.456024'>
<div class='navLinkTitle'>
BNA Manuals
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_content_menu/105.456026'>
<div class='navLinkTitle'>
BNA Portfolios
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_content_menu/105.102923'>
<div class='navLinkTitle'>
Books & Treatises
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/news/advanced_search'>
<div class='navLinkTitle'>
Search News
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/news'>
<div class='navLinkTitle'>
Legal News
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/news/topic'>
<div class='navLinkTitle'>
News by Topic
</div>
</a>
</li>
<li>
<a class='clearfix' href='/news/top_news'>
<div class='navLinkTitle'>
TOP News
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_market'>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/business_development'>
<div class='navLinkTitle'>
Business Development Center
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
Search EDGAR
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/company'>
<div class='navLinkTitle'>
Company Watchlist
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/company_search'>
<div class='navLinkTitle'>
Company Screener
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li class='last'>
<a class='clearfix' href='/report_writer'>
<div class='navLinkTitle'>
Company Report Writer
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li class='last'>
<a class='clearfix' href='/market'>
<div class='navLinkTitle'>
Market News
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>

</div>
</div>
<div class='bottomFlange'></div>
</div>
<div class='breadcrumbContainer printHide'>
<div class='breadHolder'>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_0'>
Search & Browse
</div>

<div class='breadcrumbDivider'>
/
</div>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_1'>
<a href='/conversion/resolve_search/26d9cc0d61550962980e97292d5782d1'>
Court Opinions
</a>
</div>

<div class='breadcrumbDivider'>
/
</div>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_2'>
<a href='/opinion_search/results/26d9cc0d61550962980e97292d5782d1'>
Search Results
</a>
</div>

<div class='breadcrumbDivider'>
/
</div>
</div>
</div>

</div>
<div class='page clearfix'>
<div class='content' id='page_content'>
<div id='statusHolder'></div>
<a name='primary_content'></a>

<div class='breadCrumbTitleRow clearfix eight grid'>
<div class="icon citation positive" title="Positive"></div>
<div class='title left' title='United States ex rel. Jones v. Brigham &amp; Women&amp;#x27;s Hosp., 678 F.3d 72 (1st Cir. 2012), Court Opinion'>
United States ex rel. Jones v. Brigham &amp; Women&#x27;s Hosp., 678 F.3d 72 (1st Cir. 2012),...
</div>
</div>

<div class='metadata' style='display: none'>
<div class='documentTitle'>United States ex rel. Jones v. Brigham & Women's Hosp., 678 F.3d 72 (1st Cir. 2012), Court Opinion</div>
<div class='docId'>X1HMKS8003</div>
<div class='docType'>OPINIONS</div>
<div class='case_name'>United States ex rel. Jones v. Brigham & Women's Hosp.</div>
<div class='displayCitation'>2012 BL 111983</div>
<div class='displayCitation'>678 F.3d 72</div>
<div class='displayCitation'>bna a0d1v7p2r1</div>
<div class='displayCitation'>bna a0d3n9x4e4</div>
<div class='displayCitation'>wkf1case:26061252</div>
</div>

<div class='search_outline_node_popup' style='display:none'>
<form accept-charset="UTF-8" action="/document/class_outline_search" id="search_document_node_form" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<div class='clearfix popupTitle'>
<div class='close' onclick='closePopup()'></div>
<h2>Search</h2>
</div>
<p class='searchOver'>
Search over:
<span class='search_target_node'></span>
<input class="search_source_id" id="source_id" name="source_id" type="hidden" />
<input class="search_node_id" id="search_node_id" name="search_node_id" type="hidden" />
<input class="search_service_code" id="search_service_code" name="search_service_code" type="hidden" />
<input class="search_division" id="search_division" name="search_division" type="hidden" />
<input autocomplete="off" class="search_node_text" id="search_term" name="search_term" type="text" />
</p>
<div class='clearfix'></div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right print' onclick='this.form.submit();'>
<span>
Search
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup();' type='button'>
<span>
Cancel
</span>
</button>
</div>
</form>

</div>
<div id='no_matching_keywords_popup' style='display:none'>
<div class='popupTitle clearfix'>
<div class='close' onclick='closePopup()'></div>
<h2>No Matches Found</h2>
</div>
<p>
Search term(s) not found.
</p>
<div class='popUpActions'>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup();' type='button'>
<span>
Close
</span>
</button>
</div>
</div>
<div id='copyWithCitationPopupContents' style='display:none'>
<div class='popupTitle clearfix'>
<div class='close' onclick='closePopup()'></div>
<h2>Copy with Citation</h2>
</div>
<p>
Copy the text below to paste into your document.
</p>
<div class='clearfix'>
<div class='copyWithCitationScrollBox'>
<div class='copyWithCitationArea left'>
<div class='copyWithCitationText'></div>
<div class='copyWithCitationDocumentTitle'></div>
</div>
<div class='ie9compat left'>
<img alt="" src="/images/transparency.png?1296705112" width="1" />
</div>
</div>
</div>
<div class='copyWithCitationCheckBoxHolder'>
<input checked="checked" class="linkCitation" id="link_citation" name="link_citation" onclick="updateCopyWithCitationLinks()" type="checkbox" value="true" />
Link citations to Bloomberg Law
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right' onclick='closePopup();' type='button'>
<span>
Close
</span>
</button>
</div>
</div>

<script type='text/javascript'>
  //<![CDATA[
    $('#page_content').addClass("invisible");
  //]]>
</script>
<input id="doc_id" name="doc_id" type="hidden" value="X1HMKS8003" />
<input id="hidden_document_title" name="hidden_document_title" type="hidden" value="United States ex rel. Jones v. Brigham &amp; Women's Hosp., 678 F.3d 72 (1st Cir. 2012), Court Opinion" />
<input id="hidden_case_name" name="hidden_case_name" type="hidden" value="United States ex rel. Jones v. Brigham &amp; Women's Hosp." />
<input id="hidden_case_docket" name="hidden_case_docket" type="hidden" />
<div class='toolHolder'>
<form accept-charset="UTF-8" action="" id="downloadPopupLinkForm" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div><input id="pde_location_type" name="pde_location_type" type="hidden" value="DOCUMENT" /><input id="full_doc_path" name="full_doc_path" type="hidden" value="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X1HMKS8003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="document_type" name="document_type" type="hidden" value="OPINIONS" /><input id="doc_id" name="doc_id" type="hidden" value="X1HMKS8003&amp;search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="artifact_id" name="artifact_id" type="hidden" value="X1HMKS8003" /><input id="title" name="title" type="hidden" value="United States ex rel. Jones v. Brigham &amp; Women's Hosp., 678 F.3d 72 (1st Cir. 2012), Court Opinion" /><input id="search32" name="search32" type="hidden" value="DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="citation_analysis" name="citation_analysis" type="hidden" value="POSITIVE" /><input id="context_resource_id" name="context_resource_id" type="hidden" value="26d9cc0d61550962980e97292d5782d1" /><input id="has_sidebar_info" name="has_sidebar_info" type="hidden" value="true" /><input id="tab_types_" name="tab_types[]" type="hidden" value="TAB_OPINION" /><input id="has_notepad" name="has_notepad" type="hidden" value="true" /><input id="notepad_id" name="notepad_id" type="hidden" value="X1HMKS8003" /><input id="has_headnotes" name="has_headnotes" type="hidden" value="false" /><input id="preselect_option" name="preselect_option" type="hidden" value="DOCUMENT" /></form>

<ul class='tools printHide'>
<li>
<a href="#" onclick="javascript:quickPrintLink(); return false;">Quick Print</a>

</li>
<li>
<a href="#" onclick="javascript:createFormPopupFromForm('download','downloadPopupLinkForm'); return false;">Print/Download</a>
</li>
<li>
<a href="#" onclick="javascript:createFormPopupFromForm('email','downloadPopupLinkForm'); return false;">Email</a>
</li>
<li>
<a href="#" onclick="javascript:addPopupForm('add_to_workspace','?resource_path=%2Fs%2Fopinion%2F%32%36d%39cc%30d%36%31%35%35%30%39%36%32%39%38%30e%39%37%32%39%32d%35%37%38%32d%31%2Fdocument%2FX%31HMKS%38%30%30%33%3Fsearch%33%32%3DDPNLUQBDE%31FN%30Q%33IC%35PMASPT%36%34TJMSRPDPNMSUBDECUJ%32&amp;document_type=OPINIONS', null); return false;">+ Workspace</a>
</li>
<li>
<a onclick='javascript:PDETray_default.addSelection();'>
+ Queue
</a>
</li>
<li class='last'></li>
</ul>
</div>

<div class='bootstrap printHide tabs'>
<a class='borderTab activeTab' id='tab_DOCUMENT'>
Document
</a>

<a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/bcite/X1HMKS8003/history" class="borderTab inactiveTab" id="tab_HISTORY" onclick="docTabSpinner()">Direct History</a>

<a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/bcite/X1HMKS8003/analysis" class="borderTab inactiveTab" id="tab_ANALYSIS" onclick="docTabSpinner()">Case Analysis</a>

<a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/bcite/X1HMKS8003/toa" class="borderTab inactiveTab" id="tab_TOA" onclick="docTabSpinner()">Table of Authorities</a>

<a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/related_content/X1HMKS8003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="borderTab inactiveTab" id="tab_CITING_DOCS" onclick="docTabSpinner()">Citing Documents</a>

<div class='showHide printHide'>
<div class='showHideSidebarArrow'>
<a class='bliderText' id='bliderLink'>
<span id='bliderText'>
Hide General Info & Notepad
</span>
<span id='notepadCountLabel'></span>
</a>
</div>
</div>

</div>

<!-- document -->
<script type='text/javascript'>
  //<![CDATA[
    var fluid_layout=false;
  //]]>
</script>

<!-- %table.markupContainment -->
<!-- %tbody -->
<!-- %tr -->
<!-- %td#markup_holder{:valign=>"top", :align=>"left"} -->
<div class='docHolder legal hasSearchTerms ' id='doc_holder'>
<div class='documentContent ' id='content_document'>


<script type="text/javascript">
					function Blaw__Citator()
					{
						window.location="bloomberg:bcite_url_prefix=/rest/documents/1707950211075";
					}
				</script><script type="text/javascript">
      var BLAW_TOTAL_KEYWORD = 0;
      var BLAW_CURRENT_KEYWORD = -1;
      var BLAW_LAST_COLOR = "yellow";
      var BLAW_ANCHOR_NAME = "blawkeyword";
      var BLAW_BASE_URL = document.location.href;

      function Blaw__changeCurElem(lastAnchor, newAnchor)
      {
        var baseUrl = Blaw__getBaseURL(document.location.href);
        document.location.href = baseUrl + "#" + newAnchor;
        var elem = document.getElementById(lastAnchor)[0];
        if (elem) {
          elem.style.backgroundColor = BLAW_LAST_COLOR;
        }
        elem = document.getElementById(newAnchor)[0];
        if (elem) {
          BLAW_LAST_COLOR = elem.style.backgroundColor;
          elem.style.backgroundColor = "orange";
        }
      }

      function Blaw__findNextKeyWord()
      {
        var looped = false;
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        if (++BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD) {
          BLAW_CURRENT_KEYWORD = 0;
        }

        // if index does not exist on page continue to inc until one does
        while(document.getElementById(BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD).length == 0 && BLAW_CURRENT_KEYWORD < BLAW_TOTAL_KEYWORD) {
            ++BLAW_CURRENT_KEYWORD;
            // wrap around search, once only
            if (BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD && !looped) {
              BLAW_CURRENT_KEYWORD = 0;
              looped = true;
            }
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__findPrevKeyWord()
      {
        var looped = false;
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        if (--BLAW_CURRENT_KEYWORD < 0) {
          BLAW_CURRENT_KEYWORD = BLAW_TOTAL_KEYWORD - 1;
          looped = true;
        }

        // if index does not exist on page continue to decr until one does
        while(document.getElementById(BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD).length == 0 && BLAW_CURRENT_KEYWORD >= 0) {
          --BLAW_CURRENT_KEYWORD;
          // wrap around search, once only
          if (BLAW_CURRENT_KEYWORD < 0 && !looped) {
            BLAW_CURRENT_KEYWORD = BLAW_TOTAL_KEYWORD - 1;
            looped = true;
          }
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__findNextFrom(indx)
      {
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        BLAW_CURRENT_KEYWORD = indx;
        ++BLAW_CURRENT_KEYWORD;
        if (BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD) {
          BLAW_CURRENT_KEYWORD = 0;
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__getBaseURL(url)
      {
        var reg = new RegExp("(.+)#.+$");
        var ar = reg.exec(url);
        if (ar != null) {
          return ar[1];
        } else {
          return url;
        }
      }


    </script><div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="metadata" style="display: none">
<div class="pagination_series_list">PrimaryFederalReporter,Bloomberg,</div>
<div class="citation-group">
<div class="cite" data-cite-type="PrimaryFederalReporter">678 F.3d 72</div>
<div class="cite" data-cite-type="DocketNumber">10-2301</div>
<div class="cite" data-cite-type="Bloomberg">2012 BL 111983</div>
</div>
</div>
<div align="left" class="tableofcontents">
<br CLEAR="right"><div class="page_text" style="float:right">
<b>Pagination</b><table class="page_legend" cellspacing="0">
<tr>
<td width="25%" align="left" valign="top">*</td>
<td width="50%" align="left" valign="top">F.3d </td>
</tr>
<tr>
<td width="25%" align="left" valign="top">**</td>
<td width="50%" align="left" valign="top">BL</td>
</tr>
</table>
</div>
<br>
</div>
<table><tbody><tr><td>&nbsp;</td></tr></tbody></table>
<p><center>
United States Court of Appeals, First Circuit.
</center></p>
<hr align="center" width="65%">
<p><center>
UNITED STATES, ex rel. Kenneth James JONES, Plaintiff, Appellant, Priscilla
Pitt Jones and Kenneth James Jones, Plaintiffs, v. BRIGHAM AND WOMEN'S
HOSPITAL, et al., Defendants, Appellees, Harvard Medical School, et al.,
Defendants.
</center></p>
<hr align="center" width="65%">
<p><center>
No. 10-2301.
</center></p>
<p><center>
Heard September 15, 2011. Decided May 7, 2012.
</center></p>
<div id="para2" printdualcolumn="true"><p>
Appeal from the United States District Court for the District of
Massachusetts.
<span CLASS="page_no" data-cite="678 f 3d 73" data-cite-type="PrimaryFederalReporter" data-cite-pageno="73" data-primary-citation="678 F.3d 72">[*73]</span> 
[EDITORS' NOTE: THIS PAGE CONTAINED HEADNOTES AND HEADNOTES ARE NOT AN
OFFICIAL PRODUCT OF THE COURT, THEREFORE THEY ARE NOT DISPLAYED.]
</p></div>
<div id="para2" printdualcolumn="true"><p>
<span CLASS="page_no" data-cite="678 f 3d 74" data-cite-type="PrimaryFederalReporter" data-cite-pageno="74" data-primary-citation="678 F.3d 72">[*74]</span> 
[EDITORS' NOTE: THIS PAGE CONTAINED HEADNOTES AND HEADNOTES ARE NOT AN
OFFICIAL PRODUCT OF THE COURT, THEREFORE THEY ARE NOT DISPLAYED.]
</p></div>
<span CLASS="page_no" data-cite="678 f 3d 75" data-cite-type="PrimaryFederalReporter" data-cite-pageno="75" data-primary-citation="678 F.3d 72">[*75]</span> <div id="para2" printdualcolumn="true"><p>
Jeremy L. Friedman, with whom William D. Hughes, Michael D. Kohn, Hughes &amp;
Nunn LLP, Kohn, Kohn &amp; Colapinto, LLP, and Law Office of Jeremy L. Friedman,
were on brief, for appellant.
</p></div>
<div id="para2" printdualcolumn="true"><p>
Alan D. Rose, with whom Lisa A. Tenerowicz, and Rose, Chinitz &amp; Rose, were
on brief, for appellees.
</p></div>
<div id="para2" printdualcolumn="true"><p>
Before LIPEZ, RIPPLE<a HREF="#fn*00" name="fnref_fn*00">[fn*]</a>, and HOWARD, Circuit Judges.
</p></div>
<div id="para2" printdualcolumn="true"><p>
<span class="fr"><a HREF="#fnref_fn*00" name="fn*00">[fn*]</a></span> Of the Seventh Circuit, sitting by designation.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
LIPEZ, Circuit Judge.
</p></div>
<div id="contentOpinion" printdualcolumn="true">
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  This case requires us to address claims filed pursuant to the False Claims
Act, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/XEIRUG003?jcsearch=31%20usc%203729&amp;summary=yes#jcite">31 U.S.C. &sect; 3729</a> (the "FCA"), alleging that the defendants submitted an
application to the National Institute on Aging ("NIA") for research on
Alzheimer's disease ("AD") which relied on falsified data. The district
court granted summary judgment for the defendants. We vacate that ruling.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>I.</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In 2006, Dr. Kenneth Jones ("Jones" or "Relator") filed a qui tam action
under the FCA against defendants Brigham and Women's Hospital ("BWH"),
Massachusetts General Hospital ("MGH"), Dr. Marilyn Albert, and Dr. Ronald
Killiany (collectively, the "Defendants"). Jones claimed that the Defendants
violated the FCA by including false statements in a grant application that
was submitted to the NIA, an institute within the National Institutes of
Health ("NIH"). The NIH is an agency of the United States Department of
Health and Human Services. Jones alleged that statements in the Program
Project Grant Application (the "Application") were predicated on falsified
data and that the Defendants, knowing of this falsity, failed to take
<span CLASS="page_no" data-cite="678 f 3d 76" data-cite-type="PrimaryFederalReporter" data-cite-pageno="76" data-primary-citation="678 F.3d 72">[*76]</span> 
corrective action or disavow the data. After the parties filed cross-motions
for summary judgment, the district court granted judgment for the
Defendants.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Jones timely appeals, maintaining that material factual disputes remain
concerning the Defendants' conduct. He asserts that the record supports a
conclusion that the Defendants violated the FCA by (1) "knowingly submitting
an application for a grant to the [NIH] that was based on falsified and
fraudulently manipulated study data and false statements of blinded,
reliable methodologies," and (2) receiving NIH funds while knowingly in
violation of regulations that require applicant institutions to investigate
and report allegations of scientific misconduct.<a HREF="#fn100" name="fnref_fn100">[fn1]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  After careful review of the record, we conclude that the district court
abused its discretion by excluding or failing to consider certain expert
testimony. It then committed an error of law by failing to consider
statements of the parties and experts in <span CLASS="page_no" data-cite="2012 bl 111983 p 2" data-cite-type="Bloomberg" data-cite-pageno="2" data-primary-citation="">[**2]</span> a manner required by the summary
judgment standard. When properly considered, those statements generate
genuine issues of material fact concerning some of Relator's FCA claims. We
begin our explanation of these conclusions by describing the research
project in question, Relator's concerns, and the NIH grant application
process. We then recount in some detail the contents of the parties' expert
reports. In Part II, we consider the district court's failure to examine Dr.
Daniel Teitelbaum's expert report in its entirety, its improper evaluation
of portions of other expert reports, and Relator's other claims.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>A. The Research Project</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The alleged false claims were submitted to the NIA in conjunction with a
Program Project Grant ("PPG") proposal focused on AD, a neurodegenerative
illness associated with aging. Dr. Marilyn Albert acted as the Principal
Investigator (the "PI") on the PPG and oversaw the work of both Killiany and
Jones.<a HREF="#fn200" name="fnref_fn200">[fn2]</a> The individual Defendants and Relator were part of a larger
project team working to identify early physical manifestations of AD in
certain regions of the brain and differentiate those characteristics from
changes related to normal aging. Successfully doing so would enable health
care providers to predict who will develop AD years before the individual
displays diagnosable symptoms, thereby permitting early intervention. The
NIH began funding this research in 1980 under a grant entitled "Age-related
changes of cognition in health and disease" (the "Grant"), and continued to
fund the project through 2007.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The proposed PPG consisted of four "Projects," long-term research studies
focused on related issues, and four "Cores," each of which provided various
types of support to the Projects. Killiany, a neuroanatomist, would head
"Project 3," and utilize MRI to explore regions of interest ("ROIs"),
including the EC, in the brain. Project 3 was a continuation of a study
already in progress, the preliminary results of which were published in a
2000 paper authored by Killiany, Albert, and
<span CLASS="page_no" data-cite="678 f 3d 77" data-cite-type="PrimaryFederalReporter" data-cite-pageno="77" data-primary-citation="678 F.3d 72">[*77]</span> 
Dr. Mark Moss. During the study, Killiany and another researcher ("rater"),
Dr. Teresa Gomez-Isla, developed and agreed to a protocol by which to locate
and outline the EC and other ROIs on MRI scans. According to the
Application, raters were blinded, meaning they were unaware of participants'
cognitive groupings.<a HREF="#fn300" name="fnref_fn300">[fn3]</a> Raters were provided with participants'
identification numbers and sometimes their names. Participant identification
numbers were assigned consecutively upon participants' entry into the study;
thus the numbers did not communicate information to the raters about
participants' cognitive statuses. Using a trackball mouse and "Neuroview"
software, the raters manually outlined a number of brain structures,
including the EC, on 103 participants' MRI scans.<a HREF="#fn400" name="fnref_fn400">[fn4]</a> Based on the raters'
outlines, the software calculated the volume of the traced EC, and those
calculations were later sent to Dr. Mary Hyde, the Data Manager and
Programmer for "Core B," the Data Management and Statistical Core.<a HREF="#fn500" name="fnref_fn500">[fn5]</a>
Thereafter, members of Core B, supervised <span CLASS="page_no" data-cite="2012 bl 111983 p 3" data-cite-type="Bloomberg" data-cite-pageno="3" data-primary-citation="">[**3]</span> by Jones, conducted statistical
analyses of the data to determine whether changes in the volume of the EC
could help predict which cognitively healthy people would develop AD in the
future.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Between 1995 and 1999, Killiany modified his outlining process. In his
deposition, Killiany testified that as he worked through participants'
scans, he encountered a number of "anatomical anomalies." When he
encountered such anomalies, he went back and reviewed earlier outlines to
ensure that those tracings properly considered the anatomical issue. If,
upon reviewing an outline, he felt that it should be revised, he retraced
the EC boundary, the software recalculated the volumetric data, and he
eventually sent the new data to Hyde.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>B. Relator's Concerns About the Study Data</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  As noted, the relator in this case, Jones, headed Core B. In that role, he
supervised data management, assessed project progress, analyzed project
data, and developed new analytic frameworks. In March 2001, Jones met with
Albert and Dr. Keith Johnson, the leader of Project 2. Jones and Johnson
alerted Albert that they had concerns about the data that Killiany produced
prior to 1998, which had been used to demonstrate a statistically
significant relationship between the volume of the EC and conversion to AD.
Jones noted that there was more than one
<span CLASS="page_no" data-cite="678 f 3d 78" data-cite-type="PrimaryFederalReporter" data-cite-pageno="78" data-primary-citation="678 F.3d 72">[*78]</span> 
data set for a number of study participants and expressed concern regarding
the quantitative differences between those sets. Killiany had re-measured
the scans of 30 participants &mdash; thirteen in the normal group, twelve in the
questionable group, and five in the converter group.<a HREF="#fn600" name="fnref_fn600">[fn6]</a> Jones had
particular concerns about 23 of those re-measurements. Jones told Albert
that the alterations were substantial and that, according to his analysis,
the alterations were responsible for the apparent statistical significance.
Jones asked Albert to look into the issue.<a HREF="#fn700" name="fnref_fn700">[fn7]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In response, Albert asked Dr. Mark Moss, a noted neuroanatomist who had
been involved with the PPG since its inception, to examine for accuracy the
23 re-measurements about which Jones and Johnson expressed concern. Moss
reviewed the scans in question and hand wrote notes expressing his opinion
of the accuracy of each scan. He concluded that with one exception,
Killiany's second set of measurements more accurately outlined the EC. At
Albert's request, Moss gave his notes to Killiany. Later, Killiany created a
typewritten document ostensibly containing Moss's notes,<a HREF="#fn800" name="fnref_fn800">[fn8]</a> and sent the
document to Jones and Johnson. Albert also received the typed notes and was
satisfied with Moss's conclusion that the re-measurements were more accurate
than the initial ones. Jones was unsatisfied with Moss's assessment and
asked that the scans in question be re-measured. Albert refused. In her
deposition, Albert stated that she believed that an additional set of
measurements would confuse instead of answer the question of which data set
was more accurate, so she did not have the scans re-measured. Jones
continued to work with data generated from Killiany's tracings until July
30, 2001, <span CLASS="page_no" data-cite="2012 bl 111983 p 4" data-cite-type="Bloomberg" data-cite-pageno="4" data-primary-citation="">[**4]</span> when he told Albert that he would no longer work with Killiany's
data without "neutralizing" it. After that, Jones did not work with any MRI
data generated from Killiany's tracings.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>C. The NIH Grant Application Process</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  To secure funding from the NIH for age-related research, institutions must
submit applications to the Center for Scientific Review and the NIH. The
applications are then forwarded to the NIA, where they first undergo a peer
review process conducted by a panel of independent experts in the relevant
field. The panel considers a number of factors, including the quality and
originality of the science proposed, the quality of the investigators, and
the quality of the facilities in
<span CLASS="page_no" data-cite="678 f 3d 79" data-cite-type="PrimaryFederalReporter" data-cite-pageno="79" data-primary-citation="678 F.3d 72">[*79]</span> 
which the research will take place. Based on these considerations, the
Scientific Review Administrator prepares a statement (the "Pink Sheets")
summarizing the strengths and weaknesses of a proposal. If the project is
recommended for further consideration, the National Advisory Council on
Aging will review the application, focusing its evaluation on the perceived
scientific quality of the application. After the Advisory Council's review,
final approval is committed to the discretion of the Director of the NIA.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  On October 1, 2001, Albert and MGH submitted a PPG Application for the
2002-2007 NIH funding cycle. As part of the Application, Defendants
described the results of relevant preliminary studies, including the MRI
study in which Killiany allegedly manipulated data. The Application also
outlined the methods that would be used in future research and the protocols
that the researchers planned to employ to ensure data reliability. The
Defendants did not include the allegedly false underlying data itself, but
did include a discussion of the results generated by the data and explained
why those results supported the proposed study. The Application did not
mention the existence of two sets of data or Jones's allegations of
wrongdoing. Before submission, Albert and a representative of MGH certified
the truthfulness of the Application's contents on its cover.<a HREF="#fn900" name="fnref_fn900">[fn9]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>D. The Parties' Experts</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  1. Defense Expert Dr. Andrew J. Saykin
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Saykin is a professor of radiology at the Indiana University School of
Medicine and Director of the Indiana University Center for Neuroimaging,
with a research focus on "the integration of neuroimaging and genomic data
with emphasis on early detection of Alzheimer's disease."<a HREF="#fn1000" name="fnref_fn1000">[fn10]</a> In his
report, Saykin stated that outlining "ROIs on brain scans inevitably
involves a learning curve for the neuroanatomic rater and some degree of
trial and error, especially as methods are refined and solidified." As such,
Saykin did "not believe that it was unusual or inappropriate for Killiany to
perform re-measurements to improve his accuracy of measurement, as long as
he remained blinded to the clinical status of the participants." Saykin
stated that re-measurements like those that Killiany made are normal and
need not be reported "unless the re-measurements were undertaken as part of
a formal reliability assessment <span CLASS="page_no" data-cite="2012 bl 111983 p 5" data-cite-type="Bloomberg" data-cite-pageno="5" data-primary-citation="">[**5]</span> after a change in the protocol for measuring
the EC." He also stated that he believed that "Killiany took great pains to
refine and update his measurements, following the protocol or procedural
guidelines he had developed, in an attempt to make the measurements more
accurate." Saykin concluded that Killiany was blinded at the time of the
re-measurements.
<span CLASS="page_no" data-cite="678 f 3d 80" data-cite-type="PrimaryFederalReporter" data-cite-pageno="80" data-primary-citation="678 F.3d 72">[*80]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Regarding the allegations of misconduct, Saykin stated that it was
"appropriate for [Albert] to ask a prominent neuroanatomist to review
Killiany's measurements and provide his analysis demonstrating whether the
re-measurements were done in an attempt at greater accuracy or simply to
prove the hypothesis. Since Albert concluded the former had occurred . . .
there was no need to report what had happened to anyone." Saykin stated that
if, in fact, "Killiany's first set of measurements did not demonstrate the
predictive value of the volume of the EC, those measurements were
inconsistent with the findings from many other scientific studies," as "[i]t
is now scientifically accepted that the volume of the EC is a good predictor
of conversion to AD."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  2. Relator Expert Dr. Norbert Schuff
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Not surprisingly, Relator's expert offered a contrasting conclusion.
Schuff is a professor of radiology at the University of California in San
Francisco, an investigator at the VA Medical Center in San Francisco, lead
physicist at the Center for Imaging of Neurodegenerative Diseases at the VA
Medical Center in San Francisco, and a researcher focusing on the
development of new MRI methods and concepts to identify markers of
neurodegenerative diseases, including AD.<a HREF="#fn1100" name="fnref_fn1100">[fn11]</a> He stated that while
Killiany and the other rater, Gomez-Isla, had reached an "initial conceptual
understanding [of] how to trace the [EC]" and had achieved "high inter-rater
reliability" using that protocol for the first set of measurements,
Killiany's re-measurements included "extensive" revisions that were
"frequently inconsistent with the initially adapted protocol . . . and
seemed to introduce greater rater variability." Schuff noted that any
changes to the protocol should have been discussed with Gomez-Isla, after
which Gomez-Isla would have revised her tracings and the statistics Core
would have retested reliability. Because Killiany failed to take these
steps, Schuff concluded that the only "explanation for the highly selective
revisions of the [EC] tracings in [the normal group]" was that such
"revisions were made with knowledge of the [participants'] diagnos[e]s."
Schuff noted that the objectivity of the EC measurements was material to the
NIH's and the peer reviewers' assessments of the merit of the proposed
project.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  3. Relator Expert Dr. Martha Isabel D&aacute;vila-Garc&iacute;a
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  D&aacute;vila-Garc&iacute;a, an Associate Professor at Howard University College of
Medicine,<a HREF="#fn1200" name="fnref_fn1200">[fn12]</a> explained the NIH application consideration process based on
her knowledge as a past application reviewer. She stated, among other
things, that the Application contained "a number of statements that were
material to the government's funding decision . . . including] the
preliminary data <span CLASS="page_no" data-cite="2012 bl 111983 p 6" data-cite-type="Bloomberg" data-cite-pageno="6" data-primary-citation="">[**6]</span> and progress report of the scientists' ongoing research
project, as well as the reliability of the blinded methodologies the
scientists claimed they followed in validating that data." D&aacute;vila-Garc&iacute;a
further suggested that "[e]ach of these statements was required to be made
in the grant application, and each is fundamental to the peer review ranking
of the application."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  D&aacute;vila-Garc&iacute;a also stated that Albert's inquiry into the alleged
misconduct was insufficient. Under <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X1E8LUP8?jcsearch=42%20C.F.R.%20%2050.103(d)(8)%20(2001)&amp;summary=yes#jcite">42 C.F.R. &sect; 50.103(d)(8)-(9)
(2001)</a>,<a HREF="#fn1300" name="fnref_fn1300">[fn13]</a> Albert was required
<span CLASS="page_no" data-cite="678 f 3d 81" data-cite-type="PrimaryFederalReporter" data-cite-pageno="81" data-primary-citation="678 F.3d 72">[*81]</span> 
to seek out someone free from "real or apparent conflicts of interest" with
"appropriate expertise to carry out a thorough and authoritative evaluation
of the relevant evidence in any inquiry or investigation." D&aacute;vila-Garc&iacute;a
opined that Moss was an improper choice to review Killiany's work, as Moss
"was Killiany's boss and mentor, and the chairman of the Department of
[A]natomy and [Neurobiology at Boston University School of Medicine," who
"would appear to . . . have a conflict of interest and be biased to protect
the reputation of his Department and its members."<a HREF="#fn1400" name="fnref_fn1400">[fn14]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  4. Relator Expert Dr. Daniel Teitelbaum
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Teitelbaum has a Ph.D. in engineering and has experience working with
"statistics, data analysis, predictive modeling, building computer
simulation, mathematical optimization, [and] logistics and operations
research." He stated that in his opinion, "the altered data points undo the
validity of the study's conclusions" because "[r]ather than being a
systematic visitation upon the study data, Killiany conducted the second set
of measurements by cherry-picking the study subjects in a non-random
fashion." Moreover, Teitelbaum stated that "the changes themselves were
responsible for the significance of the results Killiany claimed to achieve.
. . . Had the original data been used, Killiany could not have reported his
findings in published scientific journals or to the NIH in support of an
application for a Program Project Grant."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Regarding the reliability study, Teitelbaum explained that
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
      [w]hile minor refinements in measures may be appropriate after a
    reliability study is performed, it would be inappropriate to make
    significant alterations or to record data in deviation of the
    protocols subjected to the reliability study. It would be
    particularly unusual for there to be any changes to statistical
    measurements without a full, documented explanation as to why such
    changes were required. In this case, the magnitude of the changes
    clearly conflict [sic] with the extent of normal variations based on
    a reported 0.96 Pearson Correlation achieved.<a HREF="#fn1500" name="fnref_fn1500">[fn15]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span CLASS="page_no" data-cite="678 f 3d 82" data-cite-type="PrimaryFederalReporter" data-cite-pageno="82" data-primary-citation="678 F.3d 72">[*82]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
Teitelbaum concluded "that the data in Killiany's study which was reported
and relied upon in the 2002 PPG Renewal Application was deliberately
manipulated in order to achieve statistically significant results that could
not be achieved but for the manipulation of the data." He stated that as a
result, "Killiany reported data that had not truthfully been generated
pursuant to the stated protocols, and he negated his assertion that those
protocols had been proven to be blinded and reliable."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>II.</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  When <span CLASS="page_no" data-cite="2012 bl 111983 p 7" data-cite-type="Bloomberg" data-cite-pageno="7" data-primary-citation="">[**7]</span> Jones filed his claim in 2006,<a HREF="#fn1600" name="fnref_fn1600">[fn16]</a> the FCA imposed civil liability
on any person who either "knowingly presents, or causes to be presented to
an officer or employee of the United States Government . . . a false or
fraudulent claim for payment or approval," <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/XEIRUG003?jcsearch=31%20U.S.C.%20%203729(a)(1)&amp;summary=yes#jcite">31 U.S.C. &sect; 3729</a>(a)(1), or
"knowingly makes, uses, or causes to be made or used, a false record or
statement to get a false or fraudulent claim paid or approved by the
Government," <i><cite>id</cite>.</i> <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/XEIRUG003?jcsearch=31%20U.S.C.%20%203729(a)(2)&amp;summary=yes#jcite">&sect; 3729(a)(2)</a>.<a HREF="#fn1700" name="fnref_fn1700">[fn17]</a> A person acts "knowingly" if he or she
"(1) had actual knowledge of the information; (2) acts in deliberate
ignorance of the truth or falsity of the information; or (3) acts in
reckless disregard of the truth or falsity of the information." <i><cite>Id</cite>.</i> <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/XEIRUG003?jcsearch=31%20U.S.C.%20%203729(b)&amp;summary=yes#jcite">&sect;
3729(b)</a>.<a HREF="#fn1800" name="fnref_fn1800">[fn18]</a> A relator need not show any "proof of specific intent to
defraud." <i><a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/XEIRUG003?jcsearch=31%20U.S.C.%20%203729(b)&amp;summary=yes#jcite">Id</a>.</i> We have also "long held that the FCA is subject to a
judicially-imposed requirement that the allegedly false claim or statement
be material." <i>United States ex rel. Loughren v. Unum Grp.</i>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X1DOSSS003?jcsearch=613%20f%203d%20300&amp;summary=yes#jcite">613 F.3d 300</a>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X1DOSSS003?jcsearch=613%20f%203d%20300&amp;summary=yes#jcite">307</a>
(1st Cir.2010).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court found that Jones had not generated genuine issues of
material fact on any of the elements at issue-falsity, materiality, and
knowledge. Jones argues to the contrary. He notes that the Application
relies on Killiany's research and claims that Killiany "fraudulently altered
the MRI study data prior to 1998 to produce false results of a statistically
significant correlation between conversion to AD and volume of the EC," and
did so "after the scientists had conducted a
<span CLASS="page_no" data-cite="678 f 3d 83" data-cite-type="PrimaryFederalReporter" data-cite-pageno="83" data-primary-citation="678 F.3d 72">[*83]</span> 
reliability study showing consistency in the manual drawings of EC
boundaries." Jones claims that the alterations led to results that were
incompatible with the results of the reliability study that was conducted
and with the stated protocols. He alleges that "Albert and the defendant
hospitals submitted the subject application for NIH funding on the entire
PPG, including a separate MRI project, without disclosing to NIH the second
set of MRI data, its statistical impact or the allegations and appearance of
Killiany's misconduct."<a HREF="#fn1900" name="fnref_fn1900">[fn19]</a> Jones also asserts a series of separate errors
that he claims undermine the court's ultimate conclusion.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We review the district court's evidentiary determinations, namely, its
decisions to admit or exclude expert testimony, for abuse of discretion.
<i>Alt. Sys. Concepts, Inc. v. Synopsys, Inc.</i>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/XAQCK0?jcsearch=374%20f%203d%2023&amp;summary=yes#jcite">374 F.3d 23</a>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/XAQCK0?jcsearch=374%20f%203d%2023&amp;summary=yes#jcite">31</a> (1st Cir.2004);
<i>see also Gen. Elec. Co. v. Joiner</i>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X5CCVA?jcsearch=522%20us%20136&amp;summary=yes#jcite">522 U.S. 136</a>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X5CCVA?jcsearch=522%20us%20136&amp;summary=yes#jcite">142-43</a>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X5CCVA?jcsearch=118%20supreme%20court%20512&amp;summary=yes#jcite">118 S.Ct. 512</a>,
<a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X5CCVA?jcsearch=139%20l%20ed%202d%20508&amp;summary=yes#jcite">139 L.Ed.2d 508</a> (1997) (noting that abuse of discretion review applies to
threshold evidentiary determination made in connection with summary judgment
motions). "Evidentiary rulings have the potential to shape and winnow the
scope of the summary judgment inquiry, and a trial court should have as much
leeway in dealing with those matters at the summary judgment stage as at
trial." <i>Alt. Sys. Concepts, Inc.</i>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/XAQCK0?jcsearch=374%20f%203d%2023&amp;summary=yes#jcite">374 F.3d at 31-32</a>. A court abuses its
discretion if it commits "a material error of law," or if it "ignores a
material factor deserving significant weight, relies upon an improper
factor, or assesses only the proper mix of factors but makes a serious
mistake in evaluating them." <i>Downey v. Bob's Disc. Furniture Holdings</i>,
<a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X1ERKBK003?jcsearch=633%20f%203d%201&amp;summary=yes#jcite">633 F.3d 1</a>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X1ERKBK003?jcsearch=633%20f%203d%201&amp;summary=yes#jcite">5</a> (1st Cir.2011).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  After reviewing the district court's evidentiary determinations and
thereby settling the scope of the summary judgment <span CLASS="page_no" data-cite="2012 bl 111983 p 8" data-cite-type="Bloomberg" data-cite-pageno="8" data-primary-citation="">[**8]</span> record, we review the
court's grant of summary judgment de novo. <i>Schubert v. Nissan Motor Corp. in</i>
<i>U.S.A.</i>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/XACC5D?jcsearch=148%20f%203d%2025&amp;summary=yes#jcite">148 F.3d 25</a>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/XACC5D?jcsearch=148%20f%203d%2025&amp;summary=yes#jcite">29</a> (1st Cir.1998); <i>see also Sch. Union No. 37 v. United</i>
<i>Nat'l Ins. Co.</i>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X1E2UM6003?jcsearch=617%20f%203d%20554&amp;summary=yes#jcite">617 F.3d 554</a>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X1E2UM6003?jcsearch=617%20f%203d%20554&amp;summary=yes#jcite">558</a> (1st Cir.2010). "[W]e will reverse a grant
of summary judgment only if, making all factual inferences in favor of the
non-moving party, a rational fact-finder could resolve the legal issue for
either side." <i>D &amp; H Therapy Assocs., LLC v. Boston Mut. Life Ins. Co.</i>,
<a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X1FB9TO003?jcsearch=640%20f%203d%2027&amp;summary=yes#jcite">640 F.3d 27</a>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X1FB9TO003?jcsearch=640%20f%203d%2027&amp;summary=yes#jcite">34</a> (1st Cir.2011). Where, as here, the parties have filed
cross-motions for summary judgment, we must "determine whether either of the
parties deserves judgment as a matter of law on facts that are not
disputed." <i>Sch. Union No. 37</i>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X1E2UM6003?jcsearch=617%20f%203d%20554&amp;summary=yes#jcite">617 F.3d at 559</a> (quoting <i>Littlefield</i>
<span CLASS="page_no" data-cite="678 f 3d 84" data-cite-type="PrimaryFederalReporter" data-cite-pageno="84" data-primary-citation="678 F.3d 72">[*84]</span> 
<i>v. Acadia Ins. Co.</i>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/XGA31B?jcsearch=392%20f%203d%201&amp;summary=yes#jcite">392 F.3d 1</a>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/XGA31B?jcsearch=392%20f%203d%201&amp;summary=yes#jcite">6</a> (1st Cir.2004)) (internal quotation mark
omitted).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>A. Teitelbaum's Expert Testimony</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The Defendants filed a motion in limine to preclude Relator from offering
certain testimony and evidence, including aspects of the proposed testimony
from each of his three expert witness reports. Defendants argued, among
other things, that as a statistician, Teitelbaum was unqualified to assess
inter-rater reliability or to opine when a reliability study should be
conducted or what would be expected on the basis of reliability results. The
Defendants also challenged the admissibility of various statements in
Teitelbaum's report, arguing that his opinions lacked sufficient support or
were ambiguous, misleading, or otherwise inadmissible.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Jones notes that the district court did not directly address the motion in
limine in the memorandum accompanying its summary judgment ruling, and,
indeed, did not mention Teitelbaum's report or its admissibility at all.
Although a district court is afforded great discretion in deciding whether
to admit or exclude opinion evidence, <i>Crowe v. Marchand</i>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X17R49M003?jcsearch=506%20f%203d%2013&amp;summary=yes#jcite">506 F.3d 13</a>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X17R49M003?jcsearch=506%20f%203d%2013&amp;summary=yes#jcite">16</a>
(1st Cir.2007), it cannot abdicate that responsibility altogether. In this
case, the district court could not properly conduct its summary judgment
analysis without determining the admissibility of Teitelbaum's report, which
speaks directly to issues at the heart of Jones's claims. <i>See, e.g.,</i>
<i>Cruz-Vazquez v. Mennonite Gen. Hosp.</i>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X1DN5RQ003?jcsearch=613%20f%203d%2054&amp;summary=yes#jcite">613 F.3d 54</a>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X1DN5RQ003?jcsearch=613%20f%203d%2054&amp;summary=yes#jcite">57</a> (1st Cir.2010) (noting
that it is the district court's responsibility to "determin[e] whether to
admit or exclude expert testimony" based on an evaluation of whether "the
expert's testimony both rests on a reliable foundation and is relevant to
the task at hand" (internal quotation marks omitted)). By failing to
exercise its discretion, namely, failing to admit or exclude Teitelbaum's
report, the district court committed an error of law and, thereby, abused
its discretion. <i>See Downey</i>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X1ERKBK003?jcsearch=633%20f%203d%201&amp;summary=yes#jcite">633 F.3d at 5</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  That error, however, does not necessarily mean that we must vacate the
district court's summary judgment ruling. In the absence of the district
court's analysis regarding the dispute over Teitelbaum's qualifications, we
will make our own determination on the admissibility of Teitelbaum's
testimony in order to determine the scope of the summary judgment record.
<i>See Boston Duck Tours, LP v. Super Duck Tours, LLC</i>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X193A84003?jcsearch=531%20f%203d%201&amp;summary=yes#jcite">531 F.3d 1</a>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X193A84003?jcsearch=531%20f%203d%201&amp;summary=yes#jcite">15</a> (1st
Cir.2008) (stating that an appellate court may make a determination on "a
relevant and required <span CLASS="page_no" data-cite="2012 bl 111983 p 9" data-cite-type="Bloomberg" data-cite-pageno="9" data-primary-citation="">[**9]</span> issue" where remanding "would be a waste of judicial
resources and incompatible with the urgency of the issue before us").
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  According to the curriculum vitae submitted with his expert report,
Teitelbaum has a Ph.D. in Engineering and Public Policy. Since his
graduation in 1998, he has worked in a variety of settings with duties
related to statistics, data analysis, predictive modeling, computer
simulation, mathematical optimization, and logistics and operations
research. In rendering his opinions, Teitelbaum stated that he analyzed a
variety of materials including, among other things, Killiany's original and
revised data sets, Killiany's 2000 paper, Albert's deposition testimony,
Relator's Table, a data chart illustrating the revisions' effect on
reliability, and excerpts from the Application.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We see no bar to the admission of Teitelbaum's testimony in light of this
dispute over his qualifications. In our judgment, that dispute only goes to
the weight of his opinion testimony before a fact-finder. For purposes of
summary judgment,
<span CLASS="page_no" data-cite="678 f 3d 85" data-cite-type="PrimaryFederalReporter" data-cite-pageno="85" data-primary-citation="678 F.3d 72">[*85]</span> 
having determined that Teitelbaum's report is admissible, we ask whether his
report, along with other record evidence, generates genuine issues of
material fact as to whether Killiany falsified data while unblinded to
participants' group membership, and, thereby, undermined the study's results
and statements made by the Defendants in the PPG Application.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>B. Falsity</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Jones alleged that Defendants made three different misrepresentations in
conjunction with the NIH Application. First, Jones claimed that the
Defendants described and relied on Killiany's research without reflecting
the alleged fraudulent manipulation of the EC tracings, specifically, the
unblinded, selective enlargement of certain tracings to produce results that
exaggerated group differences.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Second, Jones alleged that the Defendants made false statements regarding
reliability methodologies in the Application by reporting a 0.96 Pearson
Correlation coefficient. Jones argued that this coefficient corresponded to
the first set of tracings that Killiany made, even though the second set was
the data that produced the statistically significant result that the
Defendants relied upon in the Application. Jones argued that when a
reliability study was conducted comparing Gomez-Isla's tracings and
Killiany's second set of measurements, the correlation coefficient dropped
to 0.54.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Finally, Jones alleged that the Defendants violated the FCA by falsely
certifying that they were in compliance with Public Health Services ("PHS")
terms and conditions and NIH Scientific Misconduct Regulations. Jones
alleged that Defendants failed to meet their obligations under
<a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X16CF798?jcsearch=42%20C.F.R.%20%2050.103(c)(3)&amp;summary=yes#jcite">42 C.F.R. &sect; 50.103(c)(3)</a>, which requires applicant institutions to take
"immediate and appropriate action as soon as misconduct on the part of
employees or persons within the organization's control is suspected or
alleged." Jones claimed that Albert's inquiry into Jones's allegations was
insufficient and that the Defendants were obligated <span CLASS="page_no" data-cite="2012 bl 111983 p 10" data-cite-type="Bloomberg" data-cite-pageno="10" data-primary-citation="">[**10]</span> to conduct a full
investigation and report the results of that investigation to the NIH.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court considered the parties' claims under an FCA falsity
framework that we have since rejected. The court stated:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
      There are three theories under which a claim may be "false or
    fraudulent" under the Act. These are: (1) factual falsity; (2) legal
    falsity under an express certification theory; and (3) legal falsity
    under an implied certification theory.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
(Footnotes omitted.) After the parties briefed this appeal, we had occasion
to clarify the proper framework for analyzing FCA claims. <i>See generally</i>
<i>Hutcheson</i>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X1FHDE6003?jcsearch=647%20f%203d%20377&amp;summary=yes#jcite">647 F.3d 377</a>; <i>see also New York v. Amgen, Inc.</i>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X1FTJR4003?jcsearch=652%20f%203d%20103&amp;summary=yes#jcite">652 F.3d 103</a> (1st
Cir.2011), <i>cert. dismissed</i>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X1GT5GI003?jcsearch=132%20S.Ct.%20993&amp;summary=yes#jcite">___ U.S. ___</a>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X1GT5GI003?jcsearch=132%20supreme%20court%20993&amp;summary=yes#jcite">132 S.Ct. 993</a>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X1GT5GI003?jcsearch=181%20l%20ed%202d%20570&amp;summary=yes#jcite">181 L.Ed.2d 570</a>
(2011). In <i>Hutcheson</i>, we rejected rigid divisions between factual and legal
falsity, and express and implied certification, noting that the text of the
FCA does not make such distinctions. The use of such categories, in "our
view[,] . . . may do more to obscure than clarify the issues before us."
<i>Hutcheson</i>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X1FHDE6003?jcsearch=647%20f%203d%20377&amp;summary=yes#jcite">647 F.3d at 385-86</a>. Instead, we take a broad view of what may
constitute a false or fraudulent statement to avoid "foreclos[ing] FCA
liability in situations that Congress intended to fall within the Act's
scope." <i></i><a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X1FHDE6003?jcsearch=647%20F.3d%20377&amp;summary=yes#jcite">Id. at 387</a> (quoting <i>United States v. Sci. Applications Int'l Corp.</i>,
<a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X1ELTV4003?jcsearch=626%20f%203d%201257&amp;summary=yes#jcite">626 F.3d 1257</a>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X1ELTV4003?jcsearch=626%20f%203d%201257&amp;summary=yes#jcite">1268</a> (D.C.Cir.2010)) (internal quotation marks omitted).
Taking this broad view does not, however, create limitless liability.
Indeed, FCA liability continues to be circumscribed by "strict enforcement
of the Act's materiality and scienter requirements."
<span CLASS="page_no" data-cite="678 f 3d 86" data-cite-type="PrimaryFederalReporter" data-cite-pageno="86" data-primary-citation="678 F.3d 72">[*86]</span> 
<i></i><a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X1FHDE6003?jcsearch=647%20F.3d%20377&amp;summary=yes#jcite">Id. at 387-88</a> (quoting <i>Sci. Applications Int'l Corp.</i>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X1ELTV4003?jcsearch=626%20f%203d%201257&amp;summary=yes#jcite">626 F.3d at 1280</a>)
(internal quotation marks omitted). We analyze each of Relator's claims by
applying the plain language of the FCA in accordance with our decision in
<i>Hutcheson.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  1. Falsified Data Generated by Unblinded Methodology
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  a. Data Generated from Re-measurements
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court found that Jones "failed to articulate how the
supposedly false data relates to a false statement in the Application," as
"[t]here is no evidence that the EC data itself was submitted as part of the
Application." Moreover, the district court found that "the act of tracing
the boundaries of the EC is subjective and requires the exercise of
scientific judgment" such that "two scientists who use the same protocol
manually to trace the EC may nevertheless obtain different results." In
dismissing the significance of the disagreement of the experts, the district
court noted that such disputes over the exercise of scientific judgment may
not form the proper basis for an FCA claim and cannot "yield a resolution
where one can state with reasonable certainty that one conclusion is true
and the other false."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Although it is true that the allegedly false EC volumetric data was not
itself included in the Application, that fact is not determinative of the
false claim allegation. The statute makes it a violation to "use[] . . . a
false record or statement to get a false or fraudulent claim paid or
approved by the Government." <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/XEIRUG003?jcsearch=31%20U.S.C.%20%203729(a)(2)&amp;summary=yes#jcite">31 U.S.C. &sect; 3729</a>(a)(2). A number of statements
in the Application demonstrate reliance on the study's conclusions and
therefore necessarily implicate the allegedly false data. For example, <span CLASS="page_no" data-cite="2012 bl 111983 p 11" data-cite-type="Bloomberg" data-cite-pageno="11" data-primary-citation="">[**11]</span> the
Application contains the following statements:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
      [W]e found that 3 measures obtained at baseline were highly
    significant predictors of who would develop AD on follow-up: (1) the
    volume of the entorhinal cortex, (2) the banks of the superior
    temporal sulcus, and (3) the caudal portion of the anterior
    cingulate. When the control subjects were compared with the
    non-demented individuals with memory impairments who ultimately
    developed AD (i.e., the `converters'), the accuracy of
    discrimination was 93% based on the MRI measure at baseline
    (sensitivity = 0.95; specificity = 0.90). . . . One hundred percent
    (100%) of normal controls could be discriminated from the patients
    with mild AD based on these 3 baseline MRI measures (Killiany et
    al., 2000). [W]e have demonstrated that to identify individuals in
    the prodromal phase of AD, regions such as the entorhinal cortex and
    the caudal portion of the anterior cingulate are highly
    discriminating. Our major finding is that measures of memory and
    executive function, or SPECT and MRI measures of brain regions
    related to these domains (such as the entorhinal cortex, the
    hippocampus, and the caudal portion of the anterior cingulate) are
    highly predictive of subsequent development of dementia among
    non-demented individuals with memory problems. . . . In the current
    application we propose to expand the longitudinal evaluation of the
    subjects to permit a more detailed understanding of the variables
    that predict course during prodromal AD.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
      The most discriminating MRI measures pertain to atrophy of the
    medial temporal lobe (particularly the entorhinal cortex), and the
    volume of anterior and posterior cingulate (Killiany et al., 2000).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
These statements rely on the data challenged by Jones as false. In the
language of the FCA, they "use . . . a false record."
<span CLASS="page_no" data-cite="678 f 3d 87" data-cite-type="PrimaryFederalReporter" data-cite-pageno="87" data-primary-citation="678 F.3d 72">[*87]</span> 
Thus premised, the statements would not be "true, complete and accurate" as
required by the certifications signed by Albert and MGH.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We agree with the district court that "[e]xpressions of opinion,
scientific judgments, or statements as to conclusions about which reasonable
minds may differ cannot be false." (citing <i>United States ex rel. Roby v.</i>
<i>Boeing Co.</i>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X4RIKU?jcsearch=100%20f%20supp%202d%20619&amp;summary=yes#jcite">100 F.Supp.2d 619</a>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X4RIKU?jcsearch=100%20f%20supp%202d%20619&amp;summary=yes#jcite">625</a> (S.D.Ohio 2000)). However, we disagree
that the creation of the data in question was necessarily a matter of
scientific judgment. The district court relied on "the undisputed fact that
tracing the EC is highly subjective and thus two scientists who use the same
protocol manually to trace the EC may nevertheless obtain different
results." This reliance, however, misses the point that the various results
produced in this case were obtained by <i>one</i> scientist purportedly using the
same protocol. Although the decision as to which measurement method to
employ was a question of scientific judgment, that is not the issue here. As
Schuff noted, Killiany and Gomez-Isla "had reached a conceptual
understanding [about] how to trace the [EC]" and used that protocol in their
initial measurements, which demonstrated high inter-rater reliability. The
real issue is whether, as Schuff opines, Killiany's revisions "substantially
deviate[<span CLASS="page_no" data-cite="2012 bl 111983 p 12" data-cite-type="Bloomberg" data-cite-pageno="12" data-primary-citation="">[**12]</span> d] . . . from the initial protocol for [the EC] that [he and
Gomez-Isla] had established to the point that the initial and new markings
[were] no longer consistent" or capable of meaningful comparison. Indeed,
Killiany himself explained that one aim of the project was to substantiate
whether "two knowledgeable individuals" could "apply a definition of the
[EC] . . . across a large number of MRI scans" and "actually even agree on
where the [EC] would be."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Killiany suggested that over the course of measuring 103 participants'
brain scans, he went through a learning curve during which he discovered
various anatomical anomalies that required modifications of his measurement
technique. He explained that after he came across this type of anomaly, he
would review previously outlined scans and evaluate them in accordance with
his now-modified technique. Although the Defendants' expert Saykin stated
that such re-measurements to improve accuracy were not "unusual or
inappropriate . . . as long as [Killiany] remained blinded to the clinical
status of the participants," the record raises questions about Killiany's
explanation.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The distribution of altered data among and within participant groups
raises the greatest concern. Of the 103 participants in the final study
population, 30 participants' scans were re-traced. Teitelbaum suggested that
if the changes were in fact revisions for accuracy, one would expect some
re-tracings to be smaller than the corresponding original tracing, resulting
in a lower volume measurement, and some re-tracings to be larger, resulting
in a higher volume measurement. Moreover, Teitelbaum stated, one would
expect to see such enlargements and reductions occurring randomly in all
groups of participants. Instead, the most frequent and dramatic changes
occur in the normal group. Measurements were changed for 13 of 24 normals
(54.2 percent), with volume increases from 0.3 to 283.3 percent.<a HREF="#fn2000" name="fnref_fn2000">[fn20]</a> Of
the 19 "converters," five were changed (26.3 percent), with volume increases
between 0.3 and 12.1 percent.<a HREF="#fn2100" name="fnref_fn2100">[fn21]</a> Of the 60 participants
<span CLASS="page_no" data-cite="678 f 3d 88" data-cite-type="PrimaryFederalReporter" data-cite-pageno="88" data-primary-citation="678 F.3d 72">[*88]</span> 
classified as "questionables," twelve were changed (20 percent), with volume
changes between -23.9 percent and 72.5 percent.<a HREF="#fn2200" name="fnref_fn2200">[fn22]</a> Moreover, the changes
within the normal group did not appear random. The six smallest initial
measurements were each increased by over 100 percent. Twelve of the smallest
thirteen original measurements were revised, while only one of the eleven
largest was (and that one by only 0.3 percent). Of course, it may be that
one of the anatomic anomalies that Killiany discovered affected only the
smallest of the original measurements. Teitelbaum suggested that if this
were the case, however, he would expect to see revisions concentrated within
the smallest original measurements in the other groups as well. Instead,
changed data points in the converter and questionable groups appear
throughout the range of initial measurements. Five changes in the
questionable group occur in the smallest 1/3 of measurements; four in the
middle 1/3; and three in the largest 1/3. In the converter group, only one
change <span CLASS="page_no" data-cite="2012 bl 111983 p 13" data-cite-type="Bloomberg" data-cite-pageno="13" data-primary-citation="">[**13]</span> appears in the nine smallest measurements. The remaining four changes
occur in the largest ten measurements.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In essence, moderate revisions occurred seemingly randomly in the
converter and questionable groups, but relatively large revisions were
concentrated in the smallest half of the control group. As Schuff stated,
most of Killiany's revisions were "quite extensive," "biased toward normal
subjects," frequently "inconsistent with the initially adapted protocol
agreed to by the raters, and "not founded on scientific reason." Schuff
further explained that "[i]f Killiany had made the second set of
measurements as part of his `learning curve,'" sound scientific practice
required him "to generate documentation and work papers in connection with
his corrections . . . and share[] what he learned with his colleagues."
Killiany testified that he does not recall discussing his decision to
perform re-measurements with anyone on the PPG, and that after he initially
discussed the EC boundaries with Gomez-Isla, the two did not have subsequent
discussion on the topic. The upward revisions in the control group were
critical to the predictive value of the study; if normal subjects showed
large EC volume changes and moved into the converter or questionable group,
the result was physical evidence of potentially great predictive
significance.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The revisions in question do not implicate questions of scientific
judgment as the district court suggested, because all the measurements in
question were purportedly generated by a single protocol that Killiany and
Gomez-Isla agreed to before beginning the measurements. Indeed, as Schuff
noted, whether Killiany's measurements were more or less accurate than the
initial measurements is not at issue. Even if Killiany's re-measurements
fall within an accepted range of scientific accuracy, a question remains as
to whether the data was falsified by intentionally exaggerating the EC
boundaries of normal subjects to achieve a desired result. We conclude that
the distribution of revisions presents a genuine issue of material fact as
to whether, as Teitelbaum put it, Killiany cherry-picked measurements to
revise in a non-random fashion "in order to produce data that would support
his hypothesis on the role of EC volume and the prediction of prodromal AD."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  b. Blinded Methodologies
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Using data provided by the defendants during discovery, Jones created a
data table
<span CLASS="page_no" data-cite="678 f 3d 89" data-cite-type="PrimaryFederalReporter" data-cite-pageno="89" data-primary-citation="678 F.3d 72">[*89]</span> 
illustrating the distribution of alterations among and within participant
groups ("Relator's Table" or "the Table"). The Table visually demonstrated
the distribution and quantitative nature of the re-measurements. It listed
the original and revised data for the 103 participants reported in
Killiany's 2000 paper. On the left side of the Table, participants were
ordered from smallest to largest according to their original measurements;
on the right side of the Table, participants were ordered from smallest to
largest according to their revised measurements. The significant volume
enlargement of eleven normal <span CLASS="page_no" data-cite="2012 bl 111983 p 14" data-cite-type="Bloomberg" data-cite-pageno="14" data-primary-citation="">[**14]</span> participants is illustrated by arrows pointing
from the participants' original measurements to their revised measurements.
Most of the arrows start from the smallest original measurements and move
downward to the same participants' revised numbers, which tend to be among
the largest revised measurements. Relator claimed that the Table
demonstrated that "Killiany selectively cherry-picked and substantially
altered the normal subjects with the smallest [ECs]." Such selective
alterations would necessarily indicate that Killiany was unblinded and aware
of participants' group affiliations.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In his deposition, Killiany stated that he was blinded to the group status
of study participants when he was making his tracings and transmitting the
volumetric data generated from those tracings. Albert stated that she
believed that Killiany had stayed blinded because he did not have access to
participants' diagnoses and because he told her that he had been blinded.
Johnson stated that it was "[his] understanding . . . that the operator who
is implementing the protocol . . . would be blinded to the classification of
the subject being [traced]." Saykin concluded that "[b]ased on all the
information [he] reviewed, [he] believed that Dr. Killiany did remain blind
to the clinical status of the cases he was analyzing or re-analyzing
an-atomically, as would be standard and appropriate in this type of
research."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Relying on Albert and Johnson's depositions,<a HREF="#fn2300" name="fnref_fn2300">[fn23]</a> the district court
found that "[a]mple record evidence shows that Killiany was . . . blinded to
the group status of the participants for which he traced the boundaries of
the EC" and to "the statistical significance of any data he produced." The
district court also noted that "Relator himself admitted at his deposition
that he has no evidence that Dr. Killiany was not following proper, blinded
methodologies when retracing EC boundaries."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  On appeal, Jones maintains that he referred only to his direct personal
knowledge when he indicated that he had no evidence that Killiany was not
blinded. Moreover, Jones insists that his personal knowledge is not
determinative. Rather, Jones argues, Teitelbaum's independent analysis of
the raw data and the Relator's Table each created a genuine issue of fact
<span CLASS="page_no" data-cite="678 f 3d 90" data-cite-type="PrimaryFederalReporter" data-cite-pageno="90" data-primary-citation="678 F.3d 72">[*90]</span> 
as to whether Killiany was blinded.<a HREF="#fn2400" name="fnref_fn2400">[fn24]</a> We agree. In light of Teitelbaum's
independent analysis and Relator's Table, there is a genuine issue of fact
as to whether Killiany was blinded or instead deliberately selected certain
participants whose data he manipulated to create the statistically
significant result that he ultimately reached. The district court erred in
concluding otherwise.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  2. Reliability Study
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Jones alleged that the Application contained misrepresentations about the
pertinent reliability study &mdash; specifically, that the study cited in the
Application was conducted on the first set of data, not the second set,
which was the data ultimately used. The Application stated that the
methodology used to manually draw image maps had demonstrated an inter-rater
reliability coefficient <span CLASS="page_no" data-cite="2012 bl 111983 p 15" data-cite-type="Bloomberg" data-cite-pageno="15" data-primary-citation="">[**15]</span> between 0.94 and 0.99. According to Albert, such
reliability numbers are "very high" and demonstrate consistency in results
between raters, here Killiany and Gomez-Isla. Relator claimed that when the
second set of data was tested for reliability, the Pearson Correlation
coefficient dropped from 0.96 to 0.54.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court disregarded Jones's testimony on this issue. Based on
Jones's experience as lead statistician for Core B, the district court
thought that Jones was "likely . . . qualified to provide expert testimony
regarding a reliability study," but nonetheless rejected his testimony
because (1) "it is not clear . . . that the Relator has put himself forth as
an expert consistent with [Federal Rule of Civil Procedure] <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X144L2A003?jcsearch=Fed.%20R.%20Civ.%20P.%2026(a)(2)&amp;summary=yes#jcite">26(a)(2)</a>" and
(2) the Relator failed to provide a proper foundation upon which to accept
his conclusions. The district court found Jones similarly deficient as a lay
witness, finding that he did "not provide sufficient competent evidence of
his personal knowledge," because (1) much of the data he received from
Killiany's research came by way of another statistician on the project, and
(2) he provided no evidence conveying "when and how the reliability study
was conducted, who randomly selected the twenty-five subjects for the study,
and who actually conducted the study."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Jones did, in fact, list himself as a non-retained expert in his Rule
26(a)(2) expert disclosure, <i>see</i> Fed.R.Civ.P. <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X144L2A003?jcsearch=Fed.%20R.%20Civ.%20P.%2026(a)(2)&amp;summary=yes#jcite">26</a>(a)(2), and, to form his
opinion, relied on personal knowledge obtained as leader of the statistical
Core and information provided by the Defendants during discovery, <i>see</i> Fed.
R.Evid. <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X135KMG003?jcsearch=Fed.%20R.%20Evid.%20702&amp;summary=yes#jcite">702</a>. The district court abused its discretion in excluding from
consideration Jones's reliability study testimony. <i>See Alt. Sys. Concepts,</i>
<i>Inc.</i>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/XAQCK0?jcsearch=374%20f%203d%2023&amp;summary=yes#jcite">374 F.3d at 32</a>. Moreover, the district court did not account for the
apparently undisputed fact that no reliability study was conducted on the
re-measurements. For example, Albert was asked during her deposition whether
"anybody . . . conducted any reliability studies on the remeasurements?" She
replied, "No. . . . We didn't have reliability data for &mdash; we didn't have
another rater available. We would have had to redo the reliability studies,
and to me the critical thing . . . was that [the measurements] were
accurate." As Teitelbaum points out, however, the question was not only one
of accuracy, but also one of reliability, specifically whether another
reliability study was necessary after Killiany's re-measurements. Albert
thought not, saying, "I thought that we were following the guidelines, that
they were the same guidelines established in the reliability study,
<span CLASS="page_no" data-cite="678 f 3d 91" data-cite-type="PrimaryFederalReporter" data-cite-pageno="91" data-primary-citation="678 F.3d 72">[*91]</span> 
and that we were applying them as best we could."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Teitelbaum, on the other hand, opined that "it was inappropriate to claim
that a blinded reliability study had been used in the generation of
preliminary data when the data reported was not generated pursuant to the
reported reliable methodologies" and had not been subject to a reliability
study. Similarly, Jones maintains that after he "analyzed the impact of the
altered data on both the reliability study and the reported volumetric data
results," it became <span CLASS="page_no" data-cite="2012 bl 111983 p 16" data-cite-type="Bloomberg" data-cite-pageno="16" data-primary-citation="">[**16]</span> clear that the changes that Killiany made were
responsible for the statistical significance of the reported data and that
the altered data resulted in a vastly lower Pearson Correlation coefficient.
Any technique modifications that Killiany made after discovering anatomical
anomalies meant that he was no longer using the precise method Gomez-Isla
had employed when she previously outlined ECs under the original
methodology. The reliability numbers published in the Application conveyed
the reliability between Killiany and Gomez-Isla under the original,
unmodified approach to outlining the EC. Relator and his experts suggest
that once Killiany deviated from this methodology, another reliability study
should have been conducted and its results included in the Application.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  There are substantial disputes here on the veracity of the reliability
study data included in the Application. The district court erred in
concluding otherwise.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  3. Misrepresentation of Compliance with the PHS Terms and Conditions
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Jones alleged that the Defendants misrepresented their compliance with the
Public Health Services ("PHS") terms and conditions, which outline
investigation and reporting requirements when scientific misconduct is
reported. Regulation <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X16CF798?jcsearch=42%20C.F.R.%20%2050.103(d)(1)&amp;summary=yes#jcite">42 C.F.R. &sect; 50.103(d)(1)</a> requires each institution to
"inquir[e] immediately into an allegation or other evidence of possible
misconduct." The institution must contact outside authorities and report any
situation in which, based on the initial inquiry, the institution determines
that an investigation is warranted. <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X16CF798?jcsearch=42%20C.F.R.%20%2050.103(d)&amp;summary=yes#jcite">42 C.F.R. &sect; 50.103(d)</a>. Jones claims that
the inquiry Moss conducted was patently inadequate to satisfy the
requirements of <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X16CF798?jcsearch=42%20C.F.R.%20%2050.103(d)&amp;summary=yes#jcite">&sect; 50.103(d)</a>. Relator also argues that Defendants were
required to create a written record of the inquiry conducted about
Killiany's alleged misconduct and report the results to the NIH Office of
Research Integrity.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Noting that Relator had not properly pled his PHS terms and conditions
certification claim in his Second Amended Complaint, the district court
stated that Relator made this claim for the first time in his motion for
summary judgment. Further, the district court stated that even if the claim
were considered on the merits, it could not withstand summary judgment. The
district court acknowledged that the "Applicant Organization" certification
signed by the MGH Director of Grants and Contracts promised that MGH would
comply with PHS terms and conditions, including <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X16CF798?jcsearch=42%20C.F.R.%20%2050.103&amp;summary=yes#jcite">42 C.F.R. &sect; 50.103</a>.<a HREF="#fn2500" name="fnref_fn2500">[fn25]</a> It
found, however, that the certification only promised compliance once a grant
was awarded. Accordingly, because the alleged misconduct occurred before
submission, it was not governed by the forward-looking certification.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We focus on the district court's procedural critique of Relator's
pleading. In so
<span CLASS="page_no" data-cite="678 f 3d 92" data-cite-type="PrimaryFederalReporter" data-cite-pageno="92" data-primary-citation="678 F.3d 72">[*92]</span> 
doing, we agree with the court that it was not until Jones filed his motion
for summary judgment that he propounded the theory that the Defendants'
failure to investigate and report any inquiry was itself a false claim,
independent <span CLASS="page_no" data-cite="2012 bl 111983 p 17" data-cite-type="Bloomberg" data-cite-pageno="17" data-primary-citation="">[**17]</span> of his claims regarding the use of falsified data not subject to
a reliability study. Under <i>Fleming v. Lind-Waldock &amp; Co.</i>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X2O27S?jcsearch=922%20f%202d%2020&amp;summary=yes#jcite">922 F.2d 20</a> (1st
Cir.1990), that was too late. <i></i><a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X2O27S?jcsearch=922%20F.2d%2020&amp;summary=yes#jcite">Id. at 24</a> ("[I]nitial failure to satisfy the
[pleading] burden in no way obligates the district court to allow the
parties an opportunity to offer matters outside the pleadings. Simply put,
summary judgment is not a procedural second chance to flesh out inadequate
pleadings."); <i>cf. Redondo Waste Sys. v. Lopez-Freytes</i>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X1GJ90O003?jcsearch=659%20f%203d%20136&amp;summary=yes#jcite">659 F.3d 136</a>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X1GJ90O003?jcsearch=659%20f%203d%20136&amp;summary=yes#jcite">141</a>
(1st Cir.2011) (affirming denial of motion to amend where complaint did not
sufficiently "apprise defendants of the claims against them," which, the
court stated, was "[t]he whole point of notice pleading").
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In an effort to avoid this conclusion, Jones points to three paragraphs in
the Second Amended Complaint that he argues demonstrate that his PHS terms
and conditions compliance claim was properly pled:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
      22. On the October 2001 grant application, defendants Albert and
    Massachusetts General Hospital certified their assurances that the
    information supplied was "true, complete and accurate," that they
    accepted the obligation to comply with Public Health Service terms
    and conditions, and that they acknowledged liability under federal
    law for false or fraudulent statements or claims.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
      23. During the course of applying for and receiving NIH grant
    funds for the 2002-2007 funding cycle, defendants, and each of them,
    made or caused to be made statements and certifications in grant
    application forms, progress reports, vouchers, requests for progress
    payments and other writings necessary for the payment of federal
    funds.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
      27. On the basis of the false and fraudulent statements,
    defendants were awarded NIH grant funds. These funds were paid out
    and disbursed to defendants over time pursuant to the Public Health
    Service terms and conditions.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  These statements do not contain any references to the Defendants' alleged
violations of the PHS terms and conditions, namely, the failure to
adequately investigate Jones's allegations of misconduct or report the Moss
inquiry that was conducted in 2001. Moreover, read in context, paragraph
27's reference to "false and fraudulent statements" does not refer to a
certification of compliance with the PHS terms and conditions. Rather, it
refers to statements set forth in the complaint (see &para; 24-26) about the
validity of the data, the blinding protocols used, and the inter-rater
reliability coefficient applicable to the reported data.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The Second Amended Complaint also generally alleged that the Defendants
"knowingly failed to take corrective action or disavow the false and
fraudulent data after learning that their representations to NIH were
false." But that allegation, too, read in context, does not aver an
independent PHS terms and conditions certification claim. Instead, it
relates to Albert's knowledge regarding the validity of Killiany's data and
the claims made in the application based on that data. Thus, as the district
court did, we conclude that any distinct, independent FCA claim resting on a
statement of adequate investigation <span CLASS="page_no" data-cite="2012 bl 111983 p 18" data-cite-type="Bloomberg" data-cite-pageno="18" data-primary-citation="">[**18]</span> or an omission of proper reporting was
not originally pled in the Second Amended Complaint. We affirm the district
court's grant of summary judgment on this
<span CLASS="page_no" data-cite="678 f 3d 93" data-cite-type="PrimaryFederalReporter" data-cite-pageno="93" data-primary-citation="678 F.3d 72">[*93]</span> 
claim.<a HREF="#fn2600" name="fnref_fn2600">[fn26]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>C. Materiality</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  A false statement is material if it has "a natural tendency to influence,
or [is] capable of influencing, the decision of the decisionmaking body to
which it was addressed." <i>Loughren</i>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X1DOSSS003?jcsearch=613%20f%203d%20300&amp;summary=yes#jcite">613 F.3d at 307</a> (alteration in original)
(quoting <i>Neder v. United States</i>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X2TB69?jcsearch=527%20us%201&amp;summary=yes#jcite">527 U.S. 1</a>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X2TB69?jcsearch=527%20us%201&amp;summary=yes#jcite">16</a>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X2TB69?jcsearch=119%20supreme%20court%201827&amp;summary=yes#jcite">119 S.Ct. 1827</a>,
<a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X2TB69?jcsearch=144%20l%20ed%202d%2035&amp;summary=yes#jcite">144 L.Ed.2d 35</a> (1999)) (internal quotation marks omitted). Jones claimed
that the allegedly manipulated data relied upon and the reliability
coefficient reported were material misrepresentations that would have a
natural tendency to influence the Application reviewers.<a HREF="#fn2700" name="fnref_fn2700">[fn27]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  1. Manipulated Data
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Because the district court failed to address Teitelbaum's and Jones's
statements and other relevant record evidence, it did not make a materiality
determination with regard to Relator's data manipulation claims. On the
record before us, we conclude that it is likely that Relator's Table,
Jones's testimony, and Teitelbaum's opinions about the manipulation of data
&mdash; if credited &mdash; would be deemed material by a fact-finder. The allegedly
false data produced the preliminary research results relied upon in the
Project 3 proposal in the Application. If established, the notion that
Killiany had been unblinded and had selectively manipulated data to produce
a statistically significant result would certainly have had "a natural
tendency to influence" the reviewers' evaluations. <i>See <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X1DOSSS003?jcsearch=613%20F.3d%20at%20307&amp;summary=yes#jcite">id.</a></i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  2. Reliability Correlation Coefficient
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Having excluded portions of the reports from experts Schuff and
D&aacute;vila-Garc&iacute;a, who alleged that the statements regarding the reliability
study were material to NIH's decision to fund the Grant, the district court
found that Jones "fail[ed] to satisfy the materiality element with respect
to the statements concerning the reliability study."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  a. Schuff's Materiality Determinations
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court found Schuff unqualified to "testify as to the
materiality of a statement regarding the NIH review process" because he did
not "list any qualifications regarding the NIH application review process or
the peer editing process." To the contrary, Schuffs curriculum vitae &mdash;
submitted with his report &mdash; listed four NIA/NIH grant proposals on which he
was a reviewer between 2006 and 2009 and numerous other experiences as a
grant and peer reviewer for other institutions as well. Schuffs curriculum
vitae also stated that he has specialized knowledge and training in relevant
topics such as neuroimaging and neurodegeneration, has published more than
150 peer-reviewed articles in those and related fields, and has acted as the
Principal Investigator on several clinical trials that utilized MRI to
examine ROIs including the EC. In light of the information in Schuffs
curriculum vitae, we conclude that the district court abused its discretion
by excluding Schuffs opinions regarding the materiality of the application
statements discussing
<span CLASS="page_no" data-cite="678 f 3d 94" data-cite-type="PrimaryFederalReporter" data-cite-pageno="94" data-primary-citation="678 F.3d 72">[*94]</span> 
reliability. Thus, we treat those statements as if they had been admitted
<span CLASS="page_no" data-cite="2012 bl 111983 p 19" data-cite-type="Bloomberg" data-cite-pageno="19" data-primary-citation="">[**19]</span> and consider them in our de novo review of the district court's summary
judgment determination.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  b. D&aacute;vila-Garc&iacute;a's Materiality Determinations
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court similarly excluded D&aacute;vila-Garc&iacute;a's statement "that the
reliability study was material to NIH's decision to fund the Grant."
Although the court stated that D&aacute;vila-Garc&iacute;a "appears qualified to opine" on
the materiality of statements in the Application concerning the reliability
study, it rejected her report because it found that she "[did] not support
her opinion with any evidence from the record." Specifically, the district
court found that although D&aacute;vila-Garc&iacute;a stated that the reliability analysis
was material because it was a required element of the application, it
excluded her opinion because she "[did] not . . . provide any support for
[her] statement from a statute, regulation, instruction manual, or . . .
personal experience[,] . . . [and did not] cite any of the reviewers'
comments from the Pink Sheets regarding the strengths and weaknesses of the
Application." Further, the district court found that the record contradicted
D&aacute;vila-Garc&iacute;a's testimony, because the Pink Sheets stated that "[t]he use of
the Pearson correlation coefficients and Student t-tests to assess
reliability, as proposed, is inadequate." Despite the reviewers' disapproval
of the proposed reliability methodology, they favorably evaluated the
Application. Therefore, the Defendants argued, the reliability study could
not have been material to the NIH's determination. The district court
agreed.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court abused its discretion by concluding that D&aacute;vila-Garc&iacute;a
did not sufficiently rely on personal experience in formulating her opinion
about the materiality of the reliability study. If a witness relies
primarily on experience, she must "explain how that experience leads to the
conclusion reached, why that experience is a sufficient basis for the
opinion, and how that experience is reliably applied to the facts."
Fed.R.Evid. <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/1?citation=FREVIDEN%20702&amp;summary=yes#jcite">702</a> advisory committee's note. D&aacute;vila-Garc&iacute;a had personal
experience as a peer reviewer and was familiar with the NIH grant
application process.<a HREF="#fn2800" name="fnref_fn2800">[fn28]</a> In her report, D&aacute;vila-Garc&iacute;a expressly stated
that "each opinion [in the report] is based upon a reasonable degree of
certainty, in light of [her] experience and background." She explained the
peer-review process that grant applications undergo at the NIH:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
      In making its ranking decision, NIH peer reviewers carefully
    consider several factors, as reflected in the NIH grant application.
    Instructions require applicants to include in the proposal a
    detailed research plan, describing the specific aims of the
    scientific project, preliminary data and progress reports on the
    work performed prior to the grant's submission, the procedures used
    and proposed to be used during the course of the project, and
    anticipated problems for the project with proposed solutions. These
    disclosures are essential to the peer-review process, as it is the
    responsibility of the reviewers to provide their best assessment of
    the chances for success and significance <span CLASS="page_no" data-cite="2012 bl 111983 p 20" data-cite-type="Bloomberg" data-cite-pageno="20" data-primary-citation="">[**20]</span> of that success on any
    given project.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span CLASS="page_no" data-cite="678 f 3d 95" data-cite-type="PrimaryFederalReporter" data-cite-pageno="95" data-primary-citation="678 F.3d 72">[*95]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
She then applied her experience and knowledge of the peer review process to
the facts in this case as she understood them:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
      Within the grant proposal at issue in this case, the applicants
    make a number of statements that were material to the government's
    funding decision. Such material information undisputedly included
    the preliminary data and progress report of the scientists' ongoing
    research project, as well as the reliability of the blinded
    methodologies the scientists claimed they followed in validating
    that data. . . . Defendants represented that reliability studies had
    confirmed a high correlation between and among blinded raters
    (measuring in ranges between 0.94 and 0.99 for Pearson r correlation
    coefficients). Each of these statements was required to be made in
    the grant application, and each is fundamental to the peer review
    ranking of the application.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Moreover, we note that the Pink Sheet statement cited by the Defendants
and the district court appeared in Section D of the Application, entitled
"Research and Design Methods." Section D outlined the <i>methodologies</i> that
would be employed in <i>future</i> studies to be conducted if grant funds were
awarded. In contrast, reliability study <i>results</i> from <i>past</i> studies were
presented in Section C, "Progress Report/Preliminary Studies." Although we
agree with the district court that the methodology concerns described in the
Pink Sheets indicate that the Defendants' proposed method of future
reliability testing was immaterial to the reviewers' decision, that
conclusion does not satisfy the materiality determination about the results
of the reliability study conducted in previous research projects. The
alleged falsity in this case does not rest upon the adequacy of the
reliability method to be employed in the future, but rather on results
allegedly already obtained in a past reliability study and relied upon by
the applicants in their proposal.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In sum, the evidence brought forth by Relator on the reliability issue
generates an issue of fact regarding materiality, specifically, whether
providing a reliability coefficient of 0.54, or stating that no reliability
study was conducted on the measurements that gave rise to the scientifically
significant results, would be capable of influencing the reviewers'
decision.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>D. Knowledge</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The text of the FCA and our case law make clear that liability cannot
arise under the FCA unless a defendant acted knowingly.
<i>See</i><a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/XEIRUG003?jcsearch=31%20U.S.C.%20%203729(a)&amp;summary=yes#jcite">31 U.S.C. &sect; 3729</a>(a); <i>Hutcheson</i>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X1FHDE6003?jcsearch=647%20f%203d%20377&amp;summary=yes#jcite">647 F.3d at 388</a>. In the district court,
Jones pointed to Relator's Table and Teitelbaum's expert report, among other
record evidence, as proof that the defendants knowingly created falsified
data and used that data to support statements in the Application espousing
the promise of research demonstrating the significant predictive value of
the volume of the EC in determining who will later develop AD.<a HREF="#fn2900" name="fnref_fn2900">[fn29]</a> As
noted, the district court abused its discretion by failing to consider
Jones's statements and Teitelbaum's report at summary judgment.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Jones also alleged <span CLASS="page_no" data-cite="2012 bl 111983 p 21" data-cite-type="Bloomberg" data-cite-pageno="21" data-primary-citation="">[**21]</span> that the parties knowingly submitted a reliability
coefficient from Killiany's study that did not incorporate his second set of
data, the set from which the study's conclusions were drawn. The district
court found that Jones failed to establish that the parties knew that they
were submitting a "statement regarding the Pearson Coefficient [that] was
in-accurate." The district court found that
<span CLASS="page_no" data-cite="678 f 3d 96" data-cite-type="PrimaryFederalReporter" data-cite-pageno="96" data-primary-citation="678 F.3d 72">[*96]</span> 
"the record [wa]s silent as to whether the reliability study was conducted
on the second set of data and whether the reference to the Pearson
Coefficient related to the first or second set of data."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  As noted, the district court's conclusion on this matter ignores Defendant
Albert's statement that she did not have an additional reliability study
performed on the re-measurements because she was focused on the accuracy and
did not have another rater available for re-measurements. <i>See <cite>supra</cite></i> Part
II.B.2. Furthermore, Killiany testified that he reviewed Gomez-Isla's
tracings sometime in 1996 or 1997 after the reliability study had been
conducted. Killiany recognized that in tracing the scans upon which the
reliability study was based, Gomez-Isla was "trying to apply the same
working definition [that he] was trying to apply at the time." At the same
time, Killiany testified that he continued tracing scans into 1998 or 1999,
making revisions when necessary, and acknowledged that it is possible that
he re-measured scans that were part of the initial reliability study well
after that study had concluded.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In light of the foregoing arguments, and construing all facts in favor of
Relator, we conclude that Jones generated a genuine issue of material fact
as to whether the Defendants acted knowingly when allegedly making false
representations in the Application.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>III.</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The dispute at the heart of this case is not about resolving which
scientific protocol produces results that fall within an acceptable range of
"accuracy." Nor is it about whether Killiany's re-measurements, the basis
for the preliminary scientific conclusions reported in the Application, are
"accurate" insofar as they fall within a range of results accepted by
qualified experts. Rather, the essential dispute is about whether Killiany
falsified scientific data by intentionally exaggerating the re-measurements
of the EC to cause proof of a particular scientific hypothesis to emerge
from the data, and whether statements made in the Application about having
used blinded, reliable methods to produce those results were true. If the
jury should find that statements in the Application are false, they must
also determine whether those statements were material and whether the
Defendants acted knowingly in violating the FCA.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Because we conclude that genuine issues of material fact remain on these
central issues, we <i>vacate</i> the district court's order and <i>remand</i> for further
proceedings consistent with this opinion. Costs are awarded to the
appellant.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>So ordered.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn100" name="fn100">[fn1]</a></span> Harvard Medical School, Harvard University, and Dr. Marie F. Kijewski
were also named as defendants in this action. The parties stipulated to
voluntary dismissal without prejudice of the case against Harvard Medical
School and Harvard University on March 17, 2009. Dr. Kijewski moved
separately to dismiss the case against her. After a hearing on the matter,
the district court granted Dr. Kijewski's motion to dismiss on July 10,
2009.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn200" name="fn200">[fn2]</a></span> Both BWH and MGH were parties to the original grant. MGH has since
merged with BWH. Albert and Killiany were both affiliated with MGH.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn300" name="fn300">[fn3]</a></span> Study participants were assigned to one of three diagnostic groups &mdash;
normal, questionable, or converter. Initially, all participants were
categorized as either "normal" (also known as "control") or "questionable."
Participants were assigned to the normal group if they met the clinical
dementia rating for normal cognition or were assigned to the questionable
group if they met the clinical dementia rating for questionable cognition.
Over the course of the study, some participants' cognitive difficulties
progressed such that they met the clinical criteria for probable AD. These
participants were reassigned to the "converter" group.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn400" name="fn400">[fn4]</a></span> Between approximately 1995 and 1999, Killiany traced the scans of 103
participants. In approximately 1996 or 1997, Gomez-Isla traced the scans of
a subset of 25 participants. In 1996 or 1997, members of Core B compared
Gomez-Isla's tracings to Killiany's tracings of the same 25 participants to
determine inter-rater reliability, an index of how close the volumetric data
generated by one rater's measurements is to that generated by another
rater's measurements of the same item.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn500" name="fn500">[fn5]</a></span> Volumetric data was sent to Core B for statistical analysis
periodically over the course of several years. Killiany stated that he
intermittently sent data to Hyde in batches, which sometimes included
re-measurements. Gomez-Isla stated that she did not recall personally
sending data to Core B.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn600" name="fn600">[fn6]</a></span> There is a dispute about the precise number of scans Killiany
re-measured and their categorization. Defendants claim that 31 scans were
retraced, of which twelve were in the normal group, eleven were in the
questionable group, two were in the converter group, and six were
unclassified. On summary judgment, we resolve such disputes in favor of the
non-moving party.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn700" name="fn700">[fn7]</a></span> The parties disagree as to whether Jones asked Albert to have someone
"verify" the data, as appellees argue, or "re-measure" the EC on the scans,
as appellant argues. In this case, we do not believe that the distinction is
meaningful. Whether Albert was asked to have the data verified or the scans
re-measured, she was on notice that Jones and Johnson had concerns about
Killiany's second set of data and, therefore, had reason to look into the
matter.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn800" name="fn800">[fn8]</a></span> Since Moss's handwritten notes no longer exist, it is impossible to
determine whether Killiany's typed notes are an exact replica. In his
deposition, Moss stated that he likely would not have used certain phrases
that appear in the version that Killiany typed. Moss said that due to the
amount of time that had passed, he could not be sure that the language that
appeared in the typed version was what he said in his handwritten notes, but
he also noted that he trusted Killiany and "assume[d]" that the typed notes
were accurate.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn900" name="fn900">[fn9]</a></span> Albert signed the following certification:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
I certify that the statements herein are true, complete and accurate to the
best of my knowledge. I am aware that any false, fictitious, or fraudulent
statements or claims may subject me to criminal, civil, or administrative
penalties. I agree to accept responsibility for the scientific conduct of
the project and to provide the required progress reports if a grant is
awarded as a result of this application.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
MGH representative Marcia L. Smith signed the following certification:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
I certify that the statements herein are true, complete and accurate to the
best of my knowledge, and accept the obligation to comply with Public Health
Service terms and conditions if a grant is awarded as a result of this
application. I am aware that any false, fictitious, or fraudulent statements
or claims may subject me to criminal, civil, or administrative penalties.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1000" name="fn1000">[fn10]</a></span> Saykin held these positions as of August 4, 2010, the date of his
expert report.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1100" name="fn1100">[fn11]</a></span> Schuff held these positions as of the date of his expert report,
August 2, 2010.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1200" name="fn1200">[fn12]</a></span> D&aacute;vila-Garc&iacute;a held this position as of the date of her expert report,
September 15, 2010.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1300" name="fn1300">[fn13]</a></span> Federal regulation 42 C.F.R. <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X16CF798?jcsearch=42%20C.F.R.%20%2050.103&amp;summary=yes#jcite">&sect; 50.103</a> describes the responsibilities
of awardee and applicant institutions that seek or receive assistance from
the Public Health Service division of the United States Department of Health
and Human Services, of which the NIH is an agency. <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X16CF798?jcsearch=42%20C.F.R.%20%2050.103%20(d)&amp;summary=yes#jcite">Subsection 50.103(d)</a>
describes the various assurances that subject institutions must make to
ensure that they are capable of dealing with and reporting possible
scientific misconduct, including "[s]ecuring necessary and appropriate
expertise to carry out a thorough and authoritative evaluation of the
relevant evidence in any inquiry or investigation," <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X16CF798?jcsearch=42%20C.F.R.%20%2050.103(d)(8)&amp;summary=yes#jcite">&sect; 50.103(d)(8)</a>, and
"Making precautions against real or apparent conflicts of interest on the
part of those involved in the inquiry or investigation," <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X16CF798?jcsearch=42%20C.F.R.%20%2050.103(d)(9)&amp;summary=yes#jcite">&sect; 50.103(d)(9)</a>.
This regulation has since been replaced by <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X12A3OE003?jcsearch=42%20C.F.R.%20%2093.100&amp;summary=yes#jcite">42 C.F.R. &sect; 93.100-319</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1400" name="fn1400">[fn14]</a></span> Killiany has held a number of positions in the Department of Anatomy
and Neurobiology at Boston University School of Medicine. He was a
postdoctoral fellow there from 1991-92, a research associate from 1994-2001,
a research assistant professor from 2001-2003, an assistant professor from
2003-2006, and, as of 2006, an associate professor in the department.
According to Killiany's curriculum vitae, he has worked on at least four
grants for which Moss was the principal investigator, and they have authored
more than thirty book chapters and peer-reviewed publications together.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1500" name="fn1500">[fn15]</a></span> The Pearson Correlation coefficient is a statistical value between
-1.0 and 1.0 used to indicate the linear relationship between two variables.
A coefficient of 0.0 indicates that there is no relationship between the
variables, and a coefficient of 1.0 indicates a perfect positive linear
relationship between the variables.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1600" name="fn1600">[fn16]</a></span> Under the FCA, the Attorney General may bring an action,
<a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/XEIRUI003?jcsearch=31%20U.S.C.%20%203730(a)&amp;summary=yes#jcite">31 U.S.C. &sect; 3730</a>(a), or an individual may bring an action "in the name of
the Government," <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/XEIRUI003?jcsearch=31%20U.S.C.%20%203730(b)(1)&amp;summary=yes#jcite">31 U.S.C. &sect; 3730</a>(b)(1). An individual who brings an action
under the FCA, who is known as a relator, may proceed regardless of whether
the Government chooses to intervene and take over the action.
<a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/XEIRUI003?jcsearch=31%20U.S.C.%20%203730(b)(4)(B)&amp;summary=yes#jcite">31 U.S.C. &sect; 3730</a>(b)(4)(B).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1700" name="fn1700">[fn17]</a></span> Our discussion relies on the provision in effect at the time Jones
filed his complaint. <i>See United States ex rel. Susan Hutcheson and Philip</i>
<i>Brown v. Blackstone Medical, Inc.</i>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X1FHDE6003?jcsearch=647%20f%203d%20377&amp;summary=yes#jcite">647 F.3d 377</a>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X1FHDE6003?jcsearch=647%20f%203d%20377&amp;summary=yes#jcite">380</a> (1st Cir.2011), <i>cert.</i>
<i>denied</i>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X1GR1CE003?jcsearch=132%20S.Ct.%20815&amp;summary=yes#jcite">___ U.S. ___</a>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X1GR1CE003?jcsearch=132%20supreme%20court%20815&amp;summary=yes#jcite">132 S.Ct. 815</a>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X1GR1CE003?jcsearch=181%20l%20ed%202d%20525&amp;summary=yes#jcite">181 L.Ed.2d 525</a> (2011). The FCA has
since been amended by the Fraud Enforcement Recovery Act ("FERA") of 2009,
Pub.L. No. <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/1?citation=USACTS%20111-21&amp;summary=yes#jcite">111-21</a>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/1?citation=123%20stat%201617&amp;summary=yes#jcite">123 Stat. 1617</a> (2009). Under FERA, an individual incurs
liability when he or she "knowingly presents, or causes to be presented, a
false or fraudulent claim for payment or approval,"
<a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/XEIRUG003?jcsearch=31%20U.S.C.%20%203729(a)(1)(A)&amp;summary=yes#jcite">31 U.S.C. &sect; 3729</a>(a)(1)(A), or "knowingly makes, uses, or causes to be made
or used, a false record or statement material to a false or fraudulent
claim," <i><cite>id</cite>.</i> <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/XEIRUG003?jcsearch=31%20U.S.C.%20%203729(a)(1)(B)&amp;summary=yes#jcite">&sect; 3729(a)(1)(B)</a>. Application of the amended language would not
affect the outcome in this case.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1800" name="fn1800">[fn18]</a></span> The parties do not distinguish how each theory of liability applies
to each particular defendant; we leave that issue open for remand. We note,
though, that while Killiany and Albert may have been directly responsible
for development of the alleged falsities at issue, MGH and BWH, which has
since acquired MGH, may be vicariously liable under the FCA for the
misrepresentations of their employees. We have long held that corporate
defendants may be subject to FCA liability when the alleged
misrepresentations are made while the employee is acting within the scope of
his or her employment. <i>See United States v. O'Connell</i>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X2K4K4?jcsearch=890%20f%202d%20563&amp;summary=yes#jcite">890 F.2d 563</a>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X2K4K4?jcsearch=890%20f%202d%20563&amp;summary=yes#jcite">568</a>
(1st Cir.1989) (noting that nothing in the FCA's text proscribes vicarious
liability, and application of vicarious liability serves the FCA's dual
purposes of restitution and deterrence).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1900" name="fn1900">[fn19]</a></span> Jones also claims that the district court abused its discretion by
not finding that the Defendants had spoliated evidence, including scientific
notebooks, MRI images, data files, emails, and any record of the internal
inquiry into the allegations of scientific misconduct. Jones argues that
such evidence should have been preserved under <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/XF5DDC003?jcsearch=45%20C.F.R.%20%2074.53(b)&amp;summary=yes#jcite">45 C.F.R. &sect; 74.53</a>(b),
"Post-Award Requirements Reports and Records." Under <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/XF5DDC003?jcsearch=45%20C.F.R.%20%2074.53(b)&amp;summary=yes#jcite">&sect; 74.53(b)</a>,
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
[f]inancial records, supporting documents, statistical records, and all
other records pertinent to an award shall be retained for a period of three
years from the date of submission of the final expenditure report. . . .
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
The district court found &mdash; as the name of the regulation suggests &mdash; that the
Post-Award Requirements are forward-looking and apply only once a grant has
been awarded. Thus, because the grant in question was not funded until 2002,
the Post-Award Requirements did not apply to records pre-dating 2002. We
agree with the district court that Jones's spoliation claim fails on this
basis. The district court also noted that applicant institutions are
required to retain documents related to misconduct inquiries for three
years, a time span that terminated in 2004 in this case. Jones gives us no
basis to doubt this determination; indeed, we note that Jones first brought
suit in 2006.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn2000" name="fn2000">[fn20]</a></span> Participants categorized as "normals" or "controls" met the clinical
dementia rating for normal cognition.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn2100" name="fn2100">[fn21]</a></span> Participants categorized as "converters" met the clinical criteria
for probable AD.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn2200" name="fn2200">[fn22]</a></span> Participants categorized as "questionables" met the clinical dementia
rating for questionable cognition.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn2300" name="fn2300">[fn23]</a></span> Johnson, the leader of Project 2, along with Jones, first reported
concerns about the data to Albert. On appeal, Defendants maintain that
"Johnson confirmed that Killiany was blinded." However, the Johnson
deposition excerpt that Defendants cite &mdash; and upon which the district court
relied &mdash; confirms only that Johnson "was generally aware that those types of
[blinding] procedures would be involved." When Johnson was asked who would
know if blinding procedures had been violated, Johnson stated that he "would
assume those involved with executing the protocol and those who would be
overseeing that execution, which would be Dr. Killiany and perhaps Dr.
Moss." It is apparent from Johnson's statement that he would not expect to
hear if Killiany had breached the protocol. Thus, the fact that Johnson did
not hear of such a breach does not conclusively resolve the question of
whether Killiany was appropriately blinded.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn2400" name="fn2400">[fn24]</a></span> Although the hearing transcript indicates that Relator's Table was in
the courtroom and was provided to the court and the Defendants during the
hearing, the district court did not acknowledge the Table in its decision.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn2500" name="fn2500">[fn25]</a></span> The district court suggested that the certification signed by MGH was
too vague to support what it styled an "express certification." We do not
address this aspect of the district court's decision other than to note that
we have since rejected the strict, categorical approach that it employed.
<i>See Hutcheson</i>, <a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X1FHDE6003?jcsearch=647%20f%203d%20377&amp;summary=yes#jcite">647 F.3d at 385-86</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn2600" name="fn2600">[fn26]</a></span> Although we affirm the district court's summary judgment
determination on Jones's misrepresentation of compliance with the PHS terms
and conditions claim, we do not suggest that the Moss inquiry is irrelevant
as a factual matter to other aspects of this case. The nature and adequacy
of the inquiry may still be relevant to Jones's other falsity claims.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn2700" name="fn2700">[fn27]</a></span> Jones also claimed that the Defendants' allegedly false certification
of compliance with the PHS terms and conditions was material. Because we
affirm the district court's summary judgment determination on that issue, we
do not address the materiality of that aspect of the certification.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn2800" name="fn2800">[fn28]</a></span> According to her curriculum vitae, D&aacute;vila-Garc&iacute;a reviewed four
articles between 1999 and 2009, and acted as a grant reviewer on six
committees between 2001 and 2010, including one NIH committee. D&aacute;vila-Garc&iacute;a
also acted as a grant consultant on two projects, one with the NIH from
2007-2012.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn2900" name="fn2900">[fn29]</a></span> The relevant statements are quoted <i><cite>supra</cite></i> Part II.B.1.a.
</p></div>
</div>
<!--BBLS DD 1707950211075-->

</div>
<div class='sideBar printHide clearfix '>
<!-- /Default state -->
<!-- /Display properties -->
<div class='tabsNotepad printHide'>
<div class='tabButtons clearfix'>
<div class='borderTab activeTab' id='buttonTab_general'>
<span>
General Info
</span>
</div>
<div class='borderTab inactiveTab' id='buttonTab_notePad'>
<span>Notepad</span>
</div>
</div>
</div>
<div class='sideBarInner clearfix'>
<div class='sideBarContent bootstrap sidebar ' id='tab_general'>
<div class='sidebarSection'>
<div class='sidebarTitle'>
<span class='left'>BCite Analysis</span>
</div>
<div class='sidebarSubsection sidebarSectionDivider bciteRenderer clearfix'>
<div class='sidebarSubhead bold'>
<a href="/bcite/X1HMKS8003/history">Direct History (2)</a>
</div>
<div class='sidebarItemLabel bold'>
No Negative Direct History
</div>
</div>
<div class='bciteRenderer clearfix sidebarSectionDivider sidebarSubsection'>
<div class='sidebarSubhead bold'>
<a href="/bcite/X1HMKS8003/analysis">Case Analysis (8)</a>
</div>
<div class='bciteResult'>
<img class='icon printOnly' src='/images/citation_icons/positive.png'>
<div class='citation icon positive printHide' title='Positive'></div>
<a class='citationAnalysisLabel' href='/bcite/X1HMKS8003/analysis?analysis=BCITE_POSITIVE_GROUP'>
Positive
</a>
<span class='citationNumberLabel'>
8
</span>
</div>
</div>
<div class='sidebarSubsection clearfix analysisLink'>
<div class='sidebarSubhead small'>
<a href="https://www.bloomberglaw.com/help/BCite_Indicators.htm" class="citatorRenderer">Description of BCite Indicators</a>
</div>
</div>

<div id='generalInfo'>
<div class='sidebarSection'>
<div class='sidebarTitle'>
<span>
General Information
</span>
</div>
<div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Result(s)</div><div class='facetItemLabel'>Order Vacated, Case Remanded</div></div>
<div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Industries</div><div class='facetItemLabel'>Hospitals</div></div><div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Related Docket(s)</div><div class='facetItemLabel'><a href="/s/opinion/26d9cc0d61550962980e97292d5782d1/document/X1Q6LFAUI182">10-02301 (1st Cir.)</a></div></div><div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Topic(s)</div><div class='facetItemLabel'>Civil Procedure</div><div class='facetItemLabel'>Evidence</div><div class='facetItemLabel'>Torts</div></div>
<div class='sidebarSubsection' id='judges_section'>
<div class='facetItemHeading'>Judge(s)</div>
<div id='judges_section_loader'></div>
</div>
</div>
</div>
</div>
</div>
<div class='sideBarContent clearfix notepad hidden' id='tab_notePad'>
<div id='notepad'>
<div class='notepadInstructions'>
Click anywhere in Notepad to add a note.
</div>
<div class='protoNote note'>
<a class='anchor'></a>
<div class='headerRow'>
<div class='ieFloat'>
<span class='title'></span>
<span class='date'></span>
</div>
<div class='ieFloat right'>
<a class='delete'>
Delete
</a>
<div class='toolDivider'>
|
</div>
<a class='edit'>
Edit
</a>
</div>
<div class='clearfix'></div>
</div>
<div class='body'></div>
<div class='footer'>
<div class='ieFloat'>
<a class='previous'>
Previous
</a>
</div>
<div class='ieFloat pageDisplay'>
<span class='numNoteDisplay'></span>
</div>
<div class='ieFloat right'>
<a class='next'>
Next
</a>
</div>
</div>
</div>
<div class='protoNoteEditor note'>
<div class='headerRow'>
<div class='ieFloat'>
<span class='title'></span>
<span class='date'></span>
</div>
</div>
<div class='body'>
<textarea class='contents'></textarea>
<div class='toolRow'>
<a class='save'>
Save
</a>
<div class='toolDivider'>
|
</div>
<a class='cancel'>
Cancel
</a>
<div class='clearfix'></div>
</div>
</div>
<div class='footer'>
<div class='ieFloat'>
<a class='previous disabled'>
Previous
</a>
</div>
<div class='ieFloat pageDisplay'>
<span class='numNoteDisplay disabled'></span>
</div>
<div class='ieFloat right'>
<a class='next disabled'>
Next
</a>
</div>
</div>
</div>
<div class='protoConfirmDelete'>
<div class='popupWindowOuter'>
<div class='popupWindowInner'>
<div class='clearfix popupTitle'>
<div class='close' onclick='closePopup()'></div>
<h2>
Delete Note
</h2>
</div>
<div class='popupContent'>
<div class='sectionLabel'>
Are you sure you want to delete this note?
<br>
<br>
<br>
<br>
</div>
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right'>
<span>
Delete
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup()'>
<span>
Cancel
</span>
</button>
</div>
</div>
</div>
</div>
</div>

</div>
</div>

</div>
<div class='clearfix'></div>
</div>

<div class='keywordSearch' id='keyword_search'>
<a href="javascript:Blaw__findPrevKeyWord();redrawPrevNextButtons();" id="keyword_search_previous">Previous Keyword</a>
|
<a href="javascript:Blaw__findNextKeyWord();redrawPrevNextButtons();" id="keyword_search_next">Next Keyword</a>
</div>
<div class='pageLoader'></div>
<div class='browserPopupContainer' id='browserPopup'>
<div class='browserTitle'>
<div class='close' onclick='$("#browserPopup").bbTocBrowser(false);'></div>
<h2 class='popup_title'></h2>
</div>
<div class='browserPopupContent popup_content' id='browserPopupContent'></div>
</div>
<div class='maskOverlay' id='ajax_browser_mask'></div>


<div class='clearfix'></div>
</div>
</div>
<!-- _enter_client_matter.haml begin -->
<div class='clientMatterContainer hidden' id='clientMatterContainer'>
<form accept-charset="UTF-8" action="/client_matter/session/create" id="startClientMatterSessionForm" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<input id="create_client_matter" name="create_client_matter" type="hidden" value="false" />
<div class='clearfix popupTitle'>
<div class='close' onclick='cancelClientMatterPopup()'></div>
<h2>
Enter a Client Matter
</h2>
</div>
<div class='popUpContent'>
<div class='clientMatterPopupHeader'>
Your firm optionally allows a client matter to be selected while you are using Bloomberg Law.
Please select from a recently used Client Matter or enter a Client Matter manually.
</div>
<div class='error' id='clientMatterLabelErrors' style='display:none'></div>
<div class='error' id='attorneyNumberLabelErrors' style='display:none'></div>
<div class='row sources clearfix'>
<div class='labelHolder'>
<span class='label'>Client Matter</span>
</div>
<div class='inputContainer'>
<input autocomplete="off" class="autocompleteTextField input_auto autocompleteForm" data-context="CLIENT_MATTERS" data-highlight-term="true" data-select-callback="applyClientMatterFromAutocompleteSelection" data-show-no-matches="false" data-url="/autocomplete/lookup" id="client_matter_label" name="client_matter_label" type="text" value="" />
<script type="text/javascript">
//<![CDATA[
jQuery().ready(function ($) { $('#client_matter_label').bbAutocomplete(); });
//]]>
</script>
</div>
</div>
<div class='row clientMatterSuppressionCheckholder' id='clientMatterSuppressionCheckholder'>
<label>
<input id="suppress_client_matter_prompt_enabled" name="suppress_client_matter_prompt_enabled" type="hidden" value="1" />
<input checked="checked" id="suppress_client_matter_prompt" name="suppress_client_matter_prompt" type="checkbox" value="1" />
<label for="suppress_client_matter_prompt">Do not remind me again this session</label>
</label>
</div>
<div class='clientMatterText'>
Please contact your administrator if you have questions about client matter.
</div>
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup right' type='submit'>
<span>
Submit
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='cancelClientMatterPopup();' type='button'>
<span>
Cancel
</span>
</button>
</div>
</form>

<div id='createClientMatterForm' style='display:none'>
<div class='clearfix popupTitle'>
<h2>
Unrecognized Client Matter
</h2>
</div>
<div class='div'>
Client Matter
<span id='new_client_matter_label'>&nbsp;</span>
does not currently exist in Bloomberg Law. Would you like to add this client matter to the system?
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right' type='button'>
<span>
Yes
</span>
</button>
<button class='bootstrap skinButton popup cancel right' type='button'>
<span>
No
</span>
</button>
</div>
</div>
</div>
<!-- _enter_client_matter.haml begin -->

<div id='loading_container'></div>
<div class='fixedControls menuHolder printHide' id='bottom_menu_row'>
<div class='menuButton' id='pde_tray_menu'>
<div class='queueImageHolder'></div>
<div class='indicator num_of_pde_tray_items'></div>
</div>
<div class='clearfix'></div>
</div>
<div class='menuItem bottomMenu' id='pde_tray'>
<div class='inner'>
<div class='heading'>
<div class='title'>
Queue
<span class='indicator num_of_pde_tray_items'></span>
<!-- =pde_tray_count_from_session -->
</div>
<div class='bootstrap closeIcon right' id='pde_tray_close_button'></div>
<div class='clearfix'></div>
</div>
<div class='actions hasItems' id='pde_tray_has_items'>
<div class='selection'>
<div class='trayCheckHolder'>
<input id='pde_tray_select_all' type='checkbox'>
</div>
Select All
</div>
<div class='tools'>
<a onclick='javascript:PDETray_default.downloadSelection();'>
Print/Download
</a>
|
<a onclick='javascript:PDETray_default.emailSelection();'>
Email
</a>
|
<a onclick='javascript:PDETray_default.workspaceSelection();'>
+ Workspace
</a>
|
<a onclick='javascript:PDETray_default.deleteSelection();'>
Delete
</a>
</div>
<div class='clearfix'></div>
</div>
<div class='actions noItems' id='pde_tray_no_items'>
<div class='title'>
You have no items in your Queue
</div>
<div class='clearfix'></div>
</div>
<div class='itemsHolder' id='pde_tray_items'></div>
</div>
</div>

<div class='maskOverlay' id='pde_tray_mask'></div>

<script language='javascript'>
var SHOW_AUDIT = false;
var ROOT_PATH = "/";
var RAILS_ROOT = "/";
var CONTEXT_PATH = "/";
var DOC_ROOT_PATH = "/s/opinion/26d9cc0d61550962980e97292d5782d1/";
var RESULTS_ROOT_PATH = "/search/results/";
var SELECTED_CONTEXT = "";
var MODULE_PATH;
MODULE_PATH = "/document";
var CRUMB_ID = "26d9cc0d61550962980e97292d5782d1";
var BILLING_CONFIGURATION = {"DOCKET":true,"NEWS":false,"LAW":true,"ADVANCED_LEGAL":true,"PATENT":true,"PATENT_ASSIGNMENT":true,"PEOPLE":false,"OPINION":true,"CITATION":false,"BREAKING":true,"DOCKET_REQUESTS":true,"COMPANY_FILINGS_EDGAR":false,"COMPANY_FILINGS_DOCKETS":false,"COMPANY_FILINGS_OTHER":false,"CORP_ACTIONS":true,"ECO_SEARCH":true,"EDGAR_SEARCH":true,"EXAMPLE_DOCUMENTS":true,"CLAUSE_SEARCH":true,"LEG":true,"REG":true,"BOOLEAN":false,"SIMPLE":false,"COMPANY_DOCKETS":true,"TOC_SEARCH":true,"IMMUTABLE_LAW_SEARCH":true};
var CONTEXT_BILLING_POLICY_KEY = "";
var ELITE_ENABLED = false;
var CLIENT_MATTER_PROMPT_ENABLED = false;
var CLIENT_MATTER_ON_LOGIN_ENABLED = false;
var SUPPRESS_CLIENT_MATTER_PROMPT = false;
var clientMatterActive = false;
var currentClientMatter = '';
var currentAttorneyNumber = '';
var clientMatterHaltedForm = null;
var USER_ID = 'un=373038066';
var SESSION_ID = '63166_a5929cc15e1bfd637ed52768bec5d196';
var NTPT_REDIRECTED_EVENT = '';
var NTPT_PGEXTRA = '&activityType=ENTITY&subActivityType=DOCUMENT_VIEWED&pageId=&activityInstanceId=ENTITYafa2e1&previousPageId=&previousActivityInstanceId=ENTITY5e0d49&previousActivityType=ENTITY&previousSubActivityType=DOCUMENT_VIEWED&previousActivityTime=2014-02-02T00:46:02-05:00';
var NTPT_GLBLEXTRA = 'un=373038066&sessionId=63166_a5929cc15e1bfd637ed52768bec5d196&auth=true';
var BROWSER_COMPATIBILITY_WARNING = 'false';
var SHOW_MODAL = false;
var JUG;
$(document).ready(function(){
setTimeout(framework_getPageState,500);
framework_bindGlobalResizeElements();
notepad_onDocumentLoaded();
<!-- /DRQS 24932463 -->
$("#downloadPopupLinkForm a").removeAttr("href");
$('#startClientMatterSessionForm').submit(function() {
  createClientMatterSessionFromForm(this);
  return false;
});

var t = $('.clientMattersTableEl');

jQuery.each(t, function(name, value) {
  try {
    var this_value =  $.trim(String(value.innerHTML));
    var this_final_value = this_value.length > 22 ? this_value.substring(0,9)+"..." : this_value;
    value.innerHTML = this_final_value;
  } catch (e) {}
});

$('#startClientMatterSessionForm .recentlyUsed td').click(function() {
  $('#client_matter_label').val($.trim($(this).attr("title")));
});

});
</script>
<script type='text/javascript'>
DOCUMENT_SHOW_SIDEBAR="true";
DOCUMENT_HAS_SIDEBAR_INFO="true";
DOCUMENT_IS_IFRAME="";
NTPT_PGEXTRA = 'documentSearchType=OPINION&docId=X1HMKS8003&docType=OPINIONS&contentClass=LEGAL&activityType=ENTITY&subActivityType=DOCUMENT_VIEWED&pageId=&activityInstanceId=ENTITY5e0d49&previousPageId=&previousActivityInstanceId=ENTITYf20cca&previousActivityType=ENTITY&previousSubActivityType=DOCUMENT_VIEWED&previousActivityTime=2014-02-02T00:45:59-05:00';
FLUID_LAYOUT="false";
FULL_DOC_ID = 'X1HMKS8003';
NOTEPAD_UUID="11082191";
NOTEPAD_DOC_ID="X1HMKS8003";
$('#page_loader').show().spin();
JUDGE_IDS=["3027828","4250670"];
JUDGE_NAMES=null;
</script>

<script src="/javascripts/activity_tracking/ni.js?1376494218" type="text/javascript"></script>
<script src="/javascripts/activity_tracking/tracking.js?1384975732" type="text/javascript"></script>
<div class='footer'>
<div class='footerContent printHide'>
<div class='logoContainer grid eight'>
<div class='copyright'>
&copy; 2014 The Bureau of National Affairs, Inc. All Rights Reserved.
 | 
<a href="#" class="menuLink" onclick="open_tos_or_privacy('X3BPR08'); return false;">Terms of Service</a>
 | 
<a href="#" class="menuLink" onclick="open_tos_or_privacy('X3BPH08'); return false;">Privacy Policy</a>
</div>
<a class='logo' href='/home'></a>
<div class='version'>
2.
231154
Gem
0.176.7
231497
 - 3.0.20
</div>
<div class='helpContainer'>
<div class='helpDesk'></div>
<a href="/help/BLAWHelpSystem.htm#Contact_Us.htm" class="menuLink">Submit Feedback</a>
 | 
<a href="mailto:blawhelp@bna.com" class="menuLink">blawhelp@bna.com</a>
</div>
</div>
</div>

</div>
</div>
</body>
</html>
